Key,Item Type,Publication Year,Author,Title,Area,Publication Title,ISBN,ISSN,DOI,Url,Abstract Note,Date,Date Added,Date Modified,Access Date,Pages,Num Pages,Issue,Volume,Number Of Volumes,Journal Abbreviation,Short Title,Series,Series Number,Series Text,Series Title,Publisher,Place,Language,Rights,Type,Archive,Archive Location,Library Catalog,Call Number,Extra,Notes,File Attachments,Link Attachments,Manual Tags,Automatic Tags,Editor,Series Editor,Translator,Contributor,Attorney Agent,Book Author,Cast Member,Commenter,Composer,Cosponsor,Counsel,Interviewer,Producer,Recipient,Reviewed Author,Scriptwriter,Words By,Guest,Number,Edition,Running Time,Scale,Medium,Artwork Size,Filing Date,Application Number,Assignee,Issuing Authority,Country,Meeting Name,Conference Name,Court,References,Reporter,Legal Status,Priority Numbers,Programming Language,Version,System,Code,Code Number,Section,Session,Committee,History,Legislative Body
QQK6J7ET,journalArticle,2016,"Phelps, Mitch; Coss, Chris; Wang, Hongyan; Cook, Matthew; Reproducibility Project: Cancer Biology",Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs,Biology,eLife,,2050-084X,10.7554/eLife.12470,https://elifesciences.org/articles/12470,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (<xref ref-type=""bibr"" rid=""bib8"">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from “Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous 'mRNAs' by Tay and colleagues, published in Cell in 2011 (<xref ref-type=""bibr"" rid=""bib23"">Tay et al., 2011</xref>). The experiments to be replicated are those reported in Figures 3C, 3D, 3G, 3H, 5A and 5B, and in Supplemental Figures 3A and B. Tay and colleagues proposed a new regulatory mechanism based on competing endogenous RNAs (ceRNAs), which regulate target genes by competitive binding of shared microRNAs. They test their model by identifying and confirming ceRNAs that target PTEN. In Figure 3A and B, they report that perturbing expression of putative PTEN ceRNAs affects expression of PTEN. This effect is dependent on functional microRNA machinery (Figure 3G and H), and affects the pathway downstream of PTEN itself (Figures 5A and B). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",3/1/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:22,e12470,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HBE6CHU3,journalArticle,2016,"Richarson, Adam D; Scott, David A; Zagnitko, Olga; Aza-Blanc, Pedro; Chang, Chih-Cheng; Russler-Germain, David A; Reproducibility Project: Cancer Biology",Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation,Biology,eLife,,2050-084X,10.7554/eLife.10860,https://elifesciences.org/articles/10860,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (Errington et al., 2014). This Registered Report describes the proposed replication plan of key experiments from “IDH mutation impairs histone demethylation and results in a block to cell differentiation” by Lu and colleagues, published in Nature in 2012 (Lu et al., 2012). The experiments that will be replicated are those reported in Figures 1B, 2A, 2B, 2D and 4D. Lu and colleagues demonstrated that expression of mutant forms of IDH1 or IDH2 caused global increases in histone methylation and increased levels of 2 hydroxyglutarate (Figure 1B). This was correlated with a block in differentiation (Figures 2A, B and D). This effect appeared to be mediated by the histone demethylase KDM4C (Figure 4D). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Scienceand Science Exchange, and the results of the replications will be published by eLife.",3/14/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:23,e10860,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
M4E5IC4Z,journalArticle,2016,"Vanden Heuvel, John P; Bullenkamp, Jessica; Reproducibility Project: Cancer Biology",Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells,Biology,eLife,,2050-084X,10/gf9h49,http://elifesciences.org/lookup/doi/10.7554/eLife.13620,,6/23/2016,10/18/2020 17:37,10/18/2020 17:37,5/22/2017 18:07,,,,5,,,Registered report,,,,,,,en,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QI33QG7V,journalArticle,2017,"Emmrich, Julius V.; Neher, Jonas J.; Boehm-Sturm, Philipp; Endres, Matthias; Dirnagl, Ulrich; Harms, Christoph",Stage 1 Registered Report: Effect of deficient phagocytosis on neuronal survival and neurological outcome after temporary middle cerebral artery occlusion (tMCAo),Biology,F1000Research,,2046-1402,10/ggb8bm,https://f1000research.com/articles/6-1827/v2,,11/14/2017,10/18/2020 17:37,10/18/2020 17:37,4/4/2018 18:06,1827,,,6,,,Stage 1 Registered Report,,,,,,,en,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
UKRJ3X2J,journalArticle,2018,"Newbury, Dianne F.; Simpson, Nuala H.; Thompson, Paul A.; Bishop, Dorothy V. M.",Stage 1 Registered Report: Variation in neurodevelopmental outcomes in children with sex chromosome trisomies: protocol for a test of the double hit hypothesis,Psychology,Wellcome Open Research,,2398-502X,10/ggb79k,https://wellcomeopenresearch.org/articles/3-10/v1,,2/12/2018,10/18/2020 17:37,10/18/2020 17:37,3/7/2018 15:44,10,,,3,,,Stage 1 Registered Report,,,,,,,en,,,,,CrossRef,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
N4RUH77R,journalArticle,2019,Emma K. Ward & Sabine Hunnius,8m_ET_Frogs,Psychology,,,,10.17605/OSF.IO/F4MHC,https://osf.io/f4mhc/,Hosted on the Open Science Framework,2/19/2019,10/18/2020 17:37,10/18/2020 17:37,2/13/2020 17:54,,,,,,,,,,,,,,en,,,,,osf.io,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISHEGDQ6,journalArticle,2020,"Schroeder, Philipp A.; Artemenko, Christina; Cipora, Krzysztof; Svaldi, Jennifer",Regional specificity of cathodal transcranial direct current stimulation (tDCS) effects on spatial-numerical associations: Comparison of four stimulation sites,Psychology,Journal of Neuroscience Research,,1097-4547,10.1002/jnr.24559,https://onlinelibrary.wiley.com/doi/abs/10.1002/jnr.24559,"Based on a theory of impulsive and reflective human behavior, we test the effects of transcranial direct current stimulation (tDCS) targeting either prefrontal or parietal cortex in either hemisphere. In a confirmatory registered report, cathodal tDCS is administered to conceptually reproduce tDCS modulations of implicit spatial-numerical associations, numerical distance effects, and response inhibition. Those cognitive operations are hypothesized to draw on left prefrontal, parietal, and right prefrontal activations, respectively, thereby susceptible to inhibitory, cathodal tDCS across those regions. Vice versa, the mutual regional and behavioral specificity of tDCS effects on these behavioral indices is examined and expected to produce double dissociations. In a mixed within-subjects (baseline, during tDCS, post-tDCS) and between-subjects (target electrode: left/right prefrontal cortex/posterior parietal cortex, or sham tDCS) design, we collect (a) confirmatory data on the robustness of cathodal tDCS effects on three behavioral effects and (b) differential data on the specificity of regional targets in male and female human participants. Results will provide crucial tests of theories of cortical organization implied by implicit associations and explicit regulation, which can direct future brain stimulation studies.",2020,10/18/2020 17:37,10/18/2020 17:37,3/20/2020 14:20,655-667,,4,98,,,Regional specificity of cathodal transcranial direct current stimulation (tDCS) effects on spatial-numerical associations,,,,,,,en,"© 2019 The Authors. Journal of Neuroscience Research published by Wiley Periodicals, Inc.",,,,Wiley Online Library,,00000  _eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.24559,,,,,working memory; prefrontal cortex; cathodal tDCS; implicit spatial-numerical associations; numerical distance effect; response inhibition; transcranial direct current stimulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
G2PXMC8W,journalArticle,2016,"Sharma, Vidhu; Young, Lisa; Cavadas, Miguel; Owen, Kate; Reproducibility Project: Cancer Biology",Registered report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation,Biology,eLife,,2050-084X,10.7554/eLife.11414,https://elifesciences.org/articles/11414,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (<xref ref-type=""bibr"" rid=""bib4"">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from “COT drives resistance to RAF inhibition through MAPK pathway reactivation” by Johannessen and colleagues, published in Nature in 2010 (<xref ref-type=""bibr"" rid=""bib10"">Johannessen et al., 2010</xref>). The key experiments to be replicated are those reported in Figures 3B, 3D-E, 3I, and 4E-F. In Figures 3B, D-E, RPMI-7951 and OUMS023 cells were reported to exhibit robust ERK/MEK activity concomitant with reduced growth sensitivity in the presence of the BRAF inhibitor PLX4720. MAP3K8 (COT/TPL2) directly regulated MEK/ERK phosphorylation, as the treatment of RPMI-7951 cells with a MAP3K8 kinase inhibitor resulted in a dose-dependent suppression of MEK/ERK activity (Figure 3I). In contrast, MAP3K8-deficient A375 cells remained sensitive to BRAF inhibition, exhibiting reduced growth and MEK/ERK activity during inhibitor treatment. To determine if RAF and MEK inhibitors together can overcome single-agent resistance, MAP3K8-expressing A375 cells treated with PLX4720 along with MEK inhibitors significantly inhibited both cell viability and ERK activation compared to treatment with PLX4720 alone, as reported in Figures 4E-F. The Reproducibility Project: Cancer Biology is collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published in eLife.",3/21/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:24,e11414,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
M88GTTMJ,report,2020,"Klein, Richard Anthony; Ropovik, Ivan; Butler, Emily; Wagemans, Fieke Maria Antoinet; IJzerman, Hans",Stage 1 RR: Social Thermoregulation in Humans: Co-Regulation of Body Temperature through Facial Expressions?,Psychology,,,,,https://osf.io/tq5sc,"We propose the first Registered Report examining social co-thermoregulation in humans, a widely studied phenomenon in ecology whereby animals help regulate body heat through conspecifics (for example, by huddling). Participants’ peripheral body temperature will be measured continuously while they view photos of their romantic partner, or strangers, making sad, neutral, angry, and happy facial expressions. If the proposed social thermoregulatory process operates as a function of partner emotional state, we predict that participants’ peripheral body temperature will increase in response to a sad partner and that these temperature responses will be strongest for high-quality (communal) relationships. For responses to angry and happy faces, we do not yet have strong priors and will analyze these with exploratory methods. We will analyze these data with linear mixed models in the lme4 R package. The study will have 95% power to detect the primary effects of interest and use a precise measure of peripheral body temperature. Results supporting such a temperature response would provide robust evidence for a social role in temperature regulation; a precisely estimated null effect would pose a strong challenge to our current understanding of social thermoregulation in humans and/or the paradigms used for studying it.",1/30/2020,10/18/2020 17:37,10/18/2020 17:37,2/13/2020 17:54,,,,,,,Stage 1 RR,,,,,PsyArXiv,,,,preprint,,,DOI.org (Crossref),,00000  DOI: 10.31234/osf.io/tq5sc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NKC2PRM7,journalArticle,2014,"van â€™ t Veer, Anna E.; Stel, MariÃ«lle; van Beest, Ilja; Gallucci, Marcello",Registered report: measuring unconscious deception detection by skin temperature,Psychology,Frontiers in Psychology,,1664-1078,10/f54t47,http://journal.frontiersin.org/article/10.3389/fpsyg.2014.00442/abstract,,5/23/2014,10/18/2020 17:37,10/18/2020 17:37,8/22/2017 14:46,,,,5,,,Registered report,,,,,,,,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34ZMXF2J,journalArticle,2014,"Greenfield, Edward; Griner, Erin; Reproducibility Project: Cancer Biology",Registered report: Widespread potential for growth factor-driven resistance to anticancer kinase inhibitors,Biology,eLife,,2050-084X,10.7554/eLife.04037,https://elifesciences.org/articles/04037,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered Report describes the proposed replication plan of key experiments from ‘Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors’ by Wilson and colleagues, published in Nature in 2012 (<xref ref-type=""bibr"" rid=""bib20"">Wilson et al., 2012</xref>). The experiments that will be replicated are those reported in Figure 2B and C. In these experiments, Wilson and colleagues show that sensitivity to receptor tyrosine kinase (RTK) inhibitors can be bypassed by various ligands through reactivation of downstream signaling pathways (Figure 2A; <xref ref-type=""bibr"" rid=""bib20"">Wilson et al., 2012</xref>), and that blocking the receptors for these bypassing ligands abrogates their ability to block sensitivity to the original RTK inhibitor (Figure 2C; <xref ref-type=""bibr"" rid=""bib20"">Wilson et al., 2012</xref>). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",12/10/2014,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:18,e04037,,,3,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WKBP6U9E,journalArticle,2014,"Chroscinski, Denise; Sampey, Darryl; Hewitt, Alex; Reproducibility Project: Cancer Biology",Registered report: Melanoma genome sequencing reveals frequent PREX2 mutations,Biology,eLife,,2050-084X,10.7554/eLife.04180,https://elifesciences.org/articles/04180,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered Report describes the proposed replication plan of key experiments from ‘Melanoma genome sequencing reveals frequent PREX2 mutations’ by Berger and colleagues, published in Nature in 2012 (<xref ref-type=""bibr"" rid=""bib1"">Berger et al., 2012</xref>). The key experiments that will be replicated are those reported in Figure 3B and Supplementary Figure S6. In these experiments, Berger and colleagues show that somatic PREX2 mutations identified through whole-genome sequencing of human melanoma can contribute to enhanced lethality of tumor xenografts in nude mice (Figure 3B, S6B, and S6C; <xref ref-type=""bibr"" rid=""bib1"">Berger et al., 2012</xref>). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",12/10/2014,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:12,e04180,,,3,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
E4RQW9S5,journalArticle,2014,"Chroscinski, Denise; Sampey, Darryl; Hewitt, Alex; Biology, Reproducibility Project: Cancer",Registered report: Melanoma genome sequencing reveals frequent PREX2 mutations,Biology,eLife,,2050-084X,10/gf9h6b,https://elifesciences.org/content/3/e04180v1,"<meta name=""DC.Rights"" content=""Copyright © 2014, Chroscinski et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.""/> <meta name=""DC.Contributor"" content=""Denise Chroscinski""/> <meta name=""DC.Contributor"" content=""Darryl Sampey""/> <meta name=""DC.Contributor"" content=""Alex Hewitt""/> <meta name=""DC.Contributor"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""DC.Contributor"" content=""Roger Davis""/> <meta name=""DC.Contributor"" content=""Elizabeth Iorns""/> <meta name=""DC.Contributor"" content=""William Gunn""/> <meta name=""DC.Contributor"" content=""Fraser Tan""/> <meta name=""DC.Contributor"" content=""Joelle Lomax""/> <meta name=""DC.Contributor"" content=""Timothy Errington""/> <meta name=""citation_funding_source"" content=""citation_funder=Laura and John Arnold Foundation;citation_grant_number=;citation_grant_recipient= ""/> <meta name=""citation_author"" content=""Denise Chroscinski""/> <meta name=""citation_author_institution"" content=""Noble Life Sciences""/> <meta name=""citation_author"" content=""Darryl Sampey""/> <meta name=""citation_author_institution"" content=""BioFactura""/> <meta name=""citation_author"" content=""Alex Hewitt""/> <meta name=""citation_author_institution"" content=""Department of Clinical Genetics""/> <meta name=""citation_author_institution"" content=""University of Melbourne""/> <meta name=""citation_author"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""citation_author_email"" content=""joelle@scienceexchange.com""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=MF. Berger;citation_author=E. Hodis;citation_author=TP. Heffernan;citation_author=YL. Deribe;citation_author=MS. Lawrence;citation_author=A. Protopopov;citation_author=E. Ivanova;citation_author=IR. Watson;citation_author=E. Nickerson;citation_author=P. Ghosh;citation_author=H. Zhang;citation_author=R. Zeid;citation_author=X. Ren;citation_author=K. Cibulskis;citation_author=AY. Sivachenko;citation_author=N. Wagle;citation_author=A. Sucker;citation_author=C. Sougnez;citation_author=R. Onofrio;citation_author=L. Ambrogio;citation_author=D. Auclair;citation_author=T. Fennell;citation_author=SL. Carter;citation_author=Y. Drier;citation_author=P. Stojanov;citation_author=MA. Singer;citation_author=D. Voet;citation_author=R. Jing;citation_author=G. Saksena;citation_author=J. Barretina;citation_author=AH. Ramos;citation_author=TJ. Pugh;citation_author=N. Stransky;citation_author=M. Parkin;citation_author=W. Winckler;citation_author=S. Mahan;citation_author=K. Ardlie;citation_author=J. Baldwin;citation_author=J. Wargo;citation_author=D. Schadendorf;citation_author=M. Meyerson;citation_author=SB. Gabriel;citation_author=TR. Golub;citation_author=SN. Wagner;citation_author=ES. Lander;citation_author=G. Getz;citation_author=L. Chin;citation_author=LA. Garraway;citation_title=Melanoma genome sequencing reveals frequent PREX2 mutations;citation_pages=502-506;citation_volume=485;citation_year=2012;citation_doi=10.1038/nature11071""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Discovery;citation_author=E. Cerami;citation_author=J. Gao;citation_author=U. Dogrusoz;citation_author=BE. Gross;citation_author=SO. Sumer;citation_author=BA. Aksoy;citation_author=A. Jacobsen;citation_author=CJ. Byrne;citation_author=ML. Heuer;citation_author=E. Larsson;citation_author=Y. Antipin;citation_author=B. Reva;citation_author=AP. Goldberg;citation_author=C. Sander;citation_author=N. Schultz;citation_title=The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data;citation_pages=401-404;citation_volume=2;citation_year=2012;citation_doi=10.1158/2159-8290.CD-12-0095""/> <meta name=""citation_reference"" content=""citation_journal_title=Science;citation_author=B. Fine;citation_author=C. Hodakoski;citation_author=S. Koujak;citation_author=T. Su;citation_author=LH. Saal;citation_author=M. Maurer;citation_author=B. Hopkins;citation_author=M. Keniry;citation_author=ML. Sulis;citation_author=S. Mense;citation_author=H. Hibshoosh;citation_author=R. Parsons;citation_title=Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a;citation_pages=1261-1265;citation_volume=325;citation_year=2009;citation_doi=10.1126/science.1173569""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=E. Hodis;citation_author=IR. Watson;citation_author=GV. Kryukov;citation_author=ST. Arold;citation_author=M. Imielinski;citation_author=JP. Theurillat;citation_author=E. Nickerson;citation_author=D. Auclair;citation_author=L. Li;citation_author=C. Place;citation_author=D. Dicara;citation_author=AH. Ramos;citation_author=MS. Lawrence;citation_author=K. Cibulskis;citation_author=A. Sivachenko;citation_author=D. Voet;citation_author=G. Saksena;citation_author=N. Stransky;citation_author=RC. Onofrio;citation_author=W. Winckler;citation_author=K. Ardlie;citation_author=N. Wagle;citation_author=J. Wargo;citation_author=K. Chong;citation_author=DL. Morton;citation_author=K. Stemke-Hale;citation_author=G. Chen;citation_author=M. Noble;citation_author=M. Meyerson;citation_author=JE. Ladbury;citation_author=MA. Davies;citation_author=JE. Gershenwald;citation_author=SN. Wagner;citation_author=DS. Hoon;citation_author=D. Schadendorf;citation_author=ES. Lander;citation_author=SB. Gabriel;citation_author=G. Getz;citation_author=LA. Garraway;citation_author=L. Chin;citation_title=A landscape of driver mutations in melanoma;citation_pages=251-263;citation_volume=150;citation_year=2012;citation_doi=10.1016/j.cell.2012.06.024""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Genetics;citation_author=M. Krauthammer;citation_author=Y. Kong;citation_author=BH. Ha;citation_author=P. Evans;citation_author=A. Bacchiocchi;citation_author=JP. McCusker;citation_author=E. Cheng;citation_author=MJ. Davis;citation_author=G. Goh;citation_author=M. Choi;citation_author=S. Ariyan;citation_author=D. Narayan;citation_author=K. Dutton-Regester;citation_author=A. Capatana;citation_author=EC. Holman;citation_author=M. Bosenberg;citation_author=M. Sznol;citation_author=HM. Kluger;citation_author=DE. Brash;citation_author=DF. Stern;citation_author=MA. Materin;citation_author=RS. Lo;citation_author=S. Mane;citation_author=S. Ma;citation_author=KK. Kidd;citation_author=NK. Hayward;citation_author=RP. Lifton;citation_author=J. Schlessinger;citation_author=TJ. Boggon;citation_author=R. Halaban;citation_title=Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma;citation_pages=1006-1014;citation_volume=44;citation_year=2012;citation_doi=10.1038/ng.2359""/> <meta name=""citation_reference"" content=""citation_journal_title=European Journal of Cell Biology;citation_author=M. Kunz;citation_title=Oncogenes in melanoma: an update;citation_pages=1-10;citation_volume=93;citation_year=2014;citation_doi=10.1016/j.ejcb.2013.12.002""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=MS. Lawrence;citation_author=P. Stojanov;citation_author=P. Polak;citation_author=GV. Kryukov;citation_author=K. Cibulskis;citation_author=A. Sivachenko;citation_author=SL. Carter;citation_author=C. Stewart;citation_author=CH. Mermel;citation_author=SA. Roberts;citation_author=A. Kiezun;citation_author=PS. Hammerman;citation_author=A. McKenna;citation_author=Y. Drier;citation_author=L. Zou;citation_author=AH. Ramos;citation_author=TJ. Pugh;citation_author=N. Stransky;citation_author=E. Helman;citation_author=J. Kim;citation_author=C. Sougnez;citation_author=L. Ambrogio;citation_author=E. Nickerson;citation_author=E. Shefler;citation_author=ML. Cortes;citation_author=D. Auclair;citation_author=G. Saksena;citation_author=D. Voet;citation_author=M. Noble;citation_author=D. DiCara;citation_author=P. Lin;citation_author=L. Lichtenstein;citation_author=DI. Heiman;citation_author=T. Fennell;citation_author=M. Imielinski;citation_author=B. Hernandez;citation_author=E. Hodis;citation_author=S. Baca;citation_author=AM. Dulak;citation_author=J. Lohr;citation_author=DA. Landau;citation_author=CJ. Wu;citation_author=J. Melendez-Zajgla;citation_author=A. Hidalgo-Miranda;citation_author=A. Koren;citation_author=SA. McCarroll;citation_author=J. Mora;citation_author=RS. Lee;citation_author=B. Crompton;citation_author=R. Onofrio;citation_author=M. Parkin;citation_author=W. Winckler;citation_author=K. Ardlie;citation_author=SB. Gabriel;citation_author=CW. Roberts;citation_author=JA. Biegel;citation_author=K. Stegmaier;citation_author=AJ. Bass;citation_author=LA. Garraway;citation_author=M. Meyerson;citation_author=TR. Golub;citation_author=DA. Gordenin;citation_author=S. Sunyaev;citation_author=ES. Lander;citation_author=G. Getz;citation_title=Mutational heterogeneity in cancer and the search for new cancer-associated genes;citation_pages=214-218;citation_volume=499;citation_year=2013;citation_doi=10.1038/nature12213""/> <meta name=""citation_reference"" content=""citation_journal_title=Neuro Oncology;citation_author=DM. Marzese;citation_author=RA. Scolyer;citation_author=M. Roque;citation_author=LM. Vargas-Roig;citation_author=JL. Huynh;citation_author=JS. Wilmott;citation_author=R. Murali;citation_author=ME. Buckland;citation_author=G. Barkhoudarian;citation_author=JF. Thompson;citation_author=DL. Morton;citation_author=DF. Kelly;citation_author=DS. Hoon;citation_title=DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations;citation_pages=1499-1509;citation_volume=16;citation_year=2014;citation_doi=10.1093/neuonc/nou107""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=TK. Ni;citation_author=SF. Landrette;citation_author=RD. Bjornson;citation_author=MW. Bosenberg;citation_author=T. Xu;citation_title=Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma;citation_pages=E3640-E3649;citation_volume=110;citation_year=2013;citation_doi=10.1073/pnas.1314435110""/> <meta name=""citation_reference"" content=""citation_journal_title=Journal of Clinical Epidemiology;citation_author=LV. Rubinstein;citation_author=MH. Gail;citation_author=TJ. Santner;citation_title=Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation;citation_pages=469-479;citation_volume=34;citation_year=1981;citation_doi=10.1016/0021-9681(81)90007-2""/> <meta name=""citation_reference"" content=""citation_journal_title=Biometrics;citation_author=DA. Schoenfeld;citation_title=Sample-size formula for the proportional-hazards regression model;citation_pages=499-503;citation_volume=39;citation_year=1983;citation_doi=10.2307/2531021""/> <meta name=""citation_reference"" content=""citation_journal_title=Genome Research;citation_author=S. Turajlic;citation_author=SJ. Furney;citation_author=MB. Lambros;citation_author=C. Mitsopoulos;citation_author=I. Kozarewa;citation_author=FC. Geyer;citation_author=A. Mackay;citation_author=J. Hakas;citation_author=M. Zvelebil;citation_author=CJ. Lord;citation_author=A. Ashworth;citation_author=M. Thomas;citation_author=G. Stamp;citation_author=J. Larkin;citation_author=JS. Reis-Filho;citation_author=R. Marais;citation_title=Whole genome sequencing of matched primary and metastatic acral melanomas;citation_pages=196-207;citation_volume=22;citation_year=2012;citation_doi=10.1101/gr.125591.111""/> <meta name=""citation_reference"" content=""citation_journal_title=Molecular Cancer Therapeutics;citation_author=J. Xia;citation_author=P. Jia;citation_author=KE. Hutchinson;citation_author=KB. Dahlman;citation_author=D. Johnson;citation_author=J. Sosman;citation_author=W. Pao;citation_author=Z. Zhao;citation_title=A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a Road Map for the study of genes with Potential clinical relevance;citation_pages=1918-1928;citation_volume=13;citation_year=2014;citation_doi=10.1158/1535-7163.MCT-13-0804""/>",12/10/2014,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:39,e04180,,,3,,,Registered report,,,,,,,en,"Copyright © 2014, Chroscinski et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.",,,,elifesciences.org,,00000  Citation Key: chroscinski_registered_2014-1 00000  PMID: 25490935,,,,,methodology; Mouse; reproducibility project: cancer biology; cancer genomic; driver mutation; melanoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z3K7H4VW,journalArticle,2015,"Raouf, Samrrah; Weston, Claire; Yucel, Nora",Registered report: Senescence surveillance of pre-malignant hepatocytes limits liver cancer development,Biology,eLife,,2050-084X,10/gf9h59,http://elifesciences.org/lookup/doi/10.7554/eLife.04105,,1/26/2015,10/18/2020 17:37,10/18/2020 17:37,5/22/2017 18:09,,,,4,,,Registered report,,,,,,,en,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
7WJMRKXW,journalArticle,2015,"Chroscinski, Denise; Maherali, Nimet; Griner, Erin; Biology, Reproducibility Project: Cancer",Registered report: The CD47-signal regulated protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors,Biology,eLife,,2050-084X,10/gf9h58,https://elifesciences.org/content/4/e04586v1,"<meta name=""DC.Rights"" content=""© 2014, Chroscinski et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.""/> <meta name=""DC.Contributor"" content=""Denise Chroscinski""/> <meta name=""DC.Contributor"" content=""Nimet Maherali""/> <meta name=""DC.Contributor"" content=""Erin Griner""/> <meta name=""DC.Contributor"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""DC.Contributor"" content=""Joan Massagué""/> <meta name=""DC.Contributor"" content=""Elizabeth Iorns""/> <meta name=""DC.Contributor"" content=""William Gunn""/> <meta name=""DC.Contributor"" content=""Fraser Tan""/> <meta name=""DC.Contributor"" content=""Joelle Lomax""/> <meta name=""DC.Contributor"" content=""Timothy Errington""/> <meta name=""citation_funding_source"" content=""citation_funder=Laura and John Arnold Foundation;citation_grant_number=;citation_grant_recipient= ""/> <meta name=""citation_author"" content=""Denise Chroscinski""/> <meta name=""citation_author_institution"" content=""Noble Life Sciences""/> <meta name=""citation_author"" content=""Nimet Maherali""/> <meta name=""citation_author_institution"" content=""Harvard Stem Cell Institute""/> <meta name=""citation_author"" content=""Erin Griner""/> <meta name=""citation_author_institution"" content=""University of Virginia""/> <meta name=""citation_author"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""citation_author_email"" content=""tim@cos.io""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=KS. Chan;citation_author=I. Espinosa;citation_author=M. Chao;citation_author=D. Wong;citation_author=L. Ailles;citation_author=M. Diehn;citation_author=H. Gill;citation_author=J. Presti Jr;citation_author=HY. Chang;citation_author=M. van de Rijn;citation_author=L. Shortliffe;citation_author=IL. Weissman;citation_title=Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells;citation_pages=14016-14021;citation_volume=106;citation_year=2009;citation_doi=10.1073/pnas.0906549106""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Research;citation_author=MP. Chao;citation_author=AA. Alizadeh;citation_author=C. Tang;citation_author=M. Jan;citation_author=R. Weissman-Tsukamoto;citation_author=F. Zhao;citation_author=CY. Park;citation_author=IL. Weissman;citation_author=R. Majeti;citation_title=Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia;citation_pages=1374-1384;citation_volume=71;citation_year=2010a;citation_doi=10.1158/0008-5472.CAN-10-2238""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=MP. Chao;citation_author=AA. Alizadeh;citation_author=C. Tang;citation_author=JH. Myklebust;citation_author=B. Varghese;citation_author=S. Gill;citation_author=M. Jan;citation_author=AC. Cha;citation_author=CK. Chan;citation_author=BT. Tan;citation_author=CY. Park;citation_author=F. Zhao;citation_author=HE. Kohrt;citation_author=R. Malumbres;citation_author=J. Briones;citation_author=RD. Gascoyne;citation_author=IS. Lossos;citation_author=R. Levy;citation_author=IL. Weissman;citation_author=R. Majeti;citation_title=Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma;citation_pages=699-713;citation_volume=142;citation_year=2010b;citation_doi=10.1016/j.cell.2010.07.044""/> <meta name=""citation_reference"" content=""citation_journal_title=Clinical Cancer Research;citation_author=S. Demaria;citation_author=MD. Volm;citation_author=RL. Shapiro;citation_author=HT. Yee;citation_author=R. Oratz;citation_author=SC. Formenti;citation_author=F. Muggia;citation_author=WF. Symmans;citation_title=Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy;citation_pages=3025-3030;citation_volume=7;citation_year=2001""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=B. Edris;citation_author=K. Weiskopf;citation_author=AK. Volkmer;citation_author=JP. Volkmer;citation_author=SB. Willingham;citation_author=H. Contreras-Trujillo;citation_author=J. Liu;citation_author=R. Majeti;citation_author=RB. West;citation_author=JA. Fletcher;citation_author=AH. Beck;citation_author=IL. Weissman;citation_author=M. van de Rijn;citation_title=Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma;citation_pages=6656-6661;citation_volume=109;citation_year=2012;citation_doi=10.1073/pnas.1121629109""/> <meta name=""citation_reference"" content=""citation_journal_title=Behavior Research Methods;citation_author=F. Faul;citation_author=E. Erdfelder;citation_author=AG. Lang;citation_author=A. Buchner;citation_title=G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences;citation_pages=175-191;citation_volume=39;citation_year=2007;citation_doi=10.3758/BF03193146""/> <meta name=""citation_reference"" content=""citation_journal_title=European Journal of Cancer;citation_author=H. Goto;citation_author=Y. Kojima;citation_author=K. Matsuda;citation_author=R. Kariya;citation_author=M. Taura;citation_author=K. Kuwahara;citation_author=H. Nagai;citation_author=H. Katano;citation_author=S. Okada;citation_title=Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma;citation_pages=1836-1846;citation_volume=50;citation_year=2014;citation_doi=10.1016/j.ejca.2014.03.004""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=S. Jaiswal;citation_author=CH. Jamieson;citation_author=WW. Pang;citation_author=CY. Park;citation_author=MP. Chao;citation_author=R. Majeti;citation_author=D. Traver;citation_author=N. van Rooijen;citation_author=IL. Weissman;citation_title=CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis;citation_pages=271-285;citation_volume=138;citation_year=2009;citation_doi=10.1016/j.cell.2009.05.046""/> <meta name=""citation_reference"" content=""citation_journal_title=Leukemia;citation_author=D. Kim;citation_author=J. Wang;citation_author=SB. Willingham;citation_author=R. Martin;citation_author=G. Wernig;citation_author=IL. Weissman;citation_title=Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells;citation_pages=2538-2545;citation_volume=26;citation_year=2012;citation_doi=10.1038/leu.2012.141""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=R. Majeti;citation_author=MP. Chao;citation_author=AA. Alizadeh;citation_author=WW. Pang;citation_author=S. Jaiswal;citation_author=KD. Gibbs Jr;citation_author=N. van Rooijen;citation_author=IL. Weissman;citation_title=CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells;citation_pages=286-299;citation_volume=138;citation_year=2009;citation_doi=10.1016/j.cell.2009.05.045""/> <meta name=""citation_reference"" content=""citation_journal_title=Science Translational Medicine;citation_author=JB. Maxhimer;citation_author=DR. Soto-Pantoja;citation_author=LA. Ridnour;citation_author=HB. Shih;citation_author=WG. Degraff;citation_author=M. Tsokos;citation_author=DA. Wink;citation_author=JS. Isenberg;citation_author=DD. Roberts;citation_title=Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling;citation_pages=3ra7;citation_volume=1;citation_year=2009;citation_doi=10.1126/scitranslmed.3000139""/> <meta name=""citation_reference"" content=""citation_journal_title=Journal of Biochemistry;citation_author=Y. Murata;citation_author=T. Kotani;citation_author=H. Ohnishi;citation_author=T. Matozaki;citation_title=The CD47-SIRPalpha signalling system: its physiological roles and therapeutic application;citation_pages=335-344;citation_volume=155;citation_year=2014;citation_doi=10.1093/jb/mvu017""/> <meta name=""citation_reference"" content=""citation_journal_title=ISRN Hematology;citation_author=PA. Oldenborg;citation_title=CD47: A Cell Surface Glycoprotein which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease;citation_pages=614619;citation_volume=2013;citation_year=2013;citation_doi=10.1155/2013/614619""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature reviews. Immunology;citation_author=IK. Poon;citation_author=CD. Lucas;citation_author=AG. Rossi;citation_author=KS. Ravichandran;citation_title=Apoptotic cell clearance: basic biology and therapeutic potential;citation_pages=166-180;citation_volume=14;citation_year=2014;citation_doi=10.1038/nri3607""/> <meta name=""citation_reference"" content=""citation_author=R Core Team;citation_title=R: a language and environment for statistical computing;citation_title=R Foundation for Statistical Computing;citation_year=2014""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=DR. Soto-Pantoja;citation_author=TW. Miller;citation_author=WA. Frazier;citation_author=DD. Roberts;citation_title=Inhibitory signaling through signal regulatory protein-a is not sufficient to explain the antitumor activities of CD47 antibodies;citation_pages=E2842;citation_volume=109;citation_year=2012;citation_doi=10.1073/pnas.1205441109""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=SB. Willingham;citation_author=JP. Volkmer;citation_author=AJ. Gentles;citation_author=D. Sahoo;citation_author=P. Dalerba;citation_author=SS. Mitra;citation_author=J. Wang;citation_author=H. Contreras-Trujillo;citation_author=R. Martin;citation_author=JD. Cohen;citation_author=P. Lovelace;citation_author=FA. Scheeren;citation_author=MP. Chao;citation_author=K. Weiskopf;citation_author=C. Tang;citation_author=AK. Volkmer;citation_author=TJ. Naik;citation_author=TA. Storm;citation_author=AR. Mosley;citation_author=B. Edris;citation_author=SM. Schmid;citation_author=CK. Sun;citation_author=MS. Chua;citation_author=O. Murillo;citation_author=P. Rajendran;citation_author=AC. Cha;citation_author=RK. Chin;citation_author=D. Kim;citation_author=M. Adorno;citation_author=T. Raveh;citation_author=D. Tseng;citation_author=S. Jaiswal;citation_author=PO. Enger;citation_author=GK. Steinberg;citation_author=G. Li;citation_author=SK. So;citation_author=R. Majeti;citation_author=GR. Harsh;citation_author=M. van de Rijn;citation_author=NN. Teng;citation_author=JB. Sunwoo;citation_author=AA. Alizadeh;citation_author=MF. Clarke;citation_author=IL. Weissman;citation_title=The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors;citation_pages=6662-6667;citation_volume=109;citation_year=2012;citation_doi=10.1073/pnas.1121623109""/>",1/26/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:39,e04586,,,4,,,Registered report,,,,,,,en,"© 2014, Chroscinski et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.",,,,elifesciences.org,,00000  Citation Key: chroscinski_registered_2015-2 00000  PMID: 25621565,,,,,methodology; Mouse; reproducibility project: cancer biology; CD47; targeted therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
7VSPKEGC,journalArticle,2015,"Eaton, Kate; Yang, Wanwan; Reproducibility Project: Cancer Biology",Registered report: Intestinal inflammation targets cancer-inducing activity of the microbiota,Biology,eLife,,2050-084X,10.7554/eLife.04186,https://elifesciences.org/articles/04186,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota’ by <xref ref-type=""bibr"" rid=""bib2"">Arthur et al. (2012)</xref>, published in Science in 2012. Arthur and colleagues identified a genotoxic island in Escherichia coli NC101 that appeared to be responsible for causing neoplastic lesions in inflammation-induced IL10−/− mice treated with azoxymethane. The experiments that will be replicated are those reported in Figure 4 (<xref ref-type=""bibr"" rid=""bib2"">Arthur et al., 2012)</xref>. Arthur and colleagues inoculated IL10−/− mice with a mutated strain of E. coli NC101 lacking the genotoxic island, and showed that those mice suffered from fewer neoplastic lesions than mice inoculated with the wild type form of E. coli NC101 (Figure 4). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",3/17/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:17,e04186,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
G7BDD6IU,journalArticle,2015,"Kandela, Irawati; Zervantonakis, Ioannis; Reproducibility Project: Cancer Biology",Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data,Biology,eLife,,2050-084X,10.7554/eLife.06847,https://elifesciences.org/articles/06847,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data’ by Sirota et al., published in Science Translational Medicine in 2011 (<xref ref-type=""bibr"" rid=""bib4"">Sirota et al., 2011</xref>). The key experiments being replicated include Figure 4C and D and Supplemental Figure 1. In these figures, Sirota and colleagues. tested a proof of concept experiment validating their prediction that cimetidine, a histamine-2 (H2) receptor agonist commonly used to treat peptic ulcers (<xref ref-type=""bibr"" rid=""bib3"">Kubecova et al., 2011</xref>), would be effective against lung adenocarcinoma (Figure 4C and D). As a control they also tested the effects of cimetidine against renal carcinoma, for which it was not predicted to be efficacious (Supplemental Figure 1). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",5/5/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:21,e06847,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMFXD8XN,journalArticle,2015,"Kandela, Irawati; Chou, James; Chow, Kartoa; Reproducibility Project: Cancer Biology",Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs,Biology,eLife,,2050-084X,10.7554/eLife.06959,https://elifesciences.org/articles/06959,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs’ by Sugahara and colleagues, published in Science in 2010 (<xref ref-type=""bibr"" rid=""bib10"">Sugahara et al., 2010</xref>). The key experiments being replicated include Figure 2 and Supplemental Figure 9A. In Figure 2, Sugahara and colleagues presented data on the tumor penetrance of doxorubicin (DOX) when co-administered with the peptide iRGD, as well as the effect of co-treatment of DOX and iRGD on tumor weight and cell death. In Supplemental Figure 9A, they tracked body weight of mice treated with DOX and iRGD to provide evidence that iRGD does not increase known DOX toxicity. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",5/22/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:20,e06959,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BIV56W36,journalArticle,2014,"Blum, David; LaBarge, Samuel; Reproducibility Project: Cancer Biology",Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion,Biology,eLife,,2050-084X,10.7554/eLife.04034,https://elifesciences.org/articles/04034,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered Report describes the proposed replication plan of key experiments from ‘Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion’ by Straussman and colleagues, published in Nature in 2012 (<xref ref-type=""bibr"" rid=""bib10"">Straussman et al., 2012</xref>). The key experiments being replicated in this study are from Figure 2A, C, and D (and Supplemental Figure 11) and Figure 4C (and Supplemental Figure 19) (<xref ref-type=""bibr"" rid=""bib10"">Straussman et al., 2012</xref>). Figure 2 demonstrates resistance to drug sensitivity conferred by co-culture with some stromal cell lines and identifies the secreted factor responsible as HGF. In Figure 4, Straussman and colleagues show that blocking the HGF receptor MET abrogates HGF’s rescue of drug sensitivity. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",12/10/2014,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:11,e04034,,,3,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RDZBS6E4,journalArticle,2015,"Blum, David; Hao, Haiping; McCarthy, Michael; Reproducibility Project: Cancer Biology",Registered report: Transcriptional amplification in tumor cells with elevated c-Myc,Biology,eLife,,2050-084X,10.7554/eLife.04024,https://elifesciences.org/articles/04024,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Transcriptional amplification in tumor cells with elevated c-Myc’ by <xref ref-type=""bibr"" rid=""bib5"">Lin et al. (2012)</xref>, published in Cell in 2012. The experiments that will be replicated are those reported in Figures 3E and 3F. In these experiments, elevated levels of c-Myc in the P493-6 cell model of Burkitt's lymphoma results in an increase of the total level of RNA using UV/VIS spectrophotometry (Figure 3E; <xref ref-type=""bibr"" rid=""bib5"">Lin et al., 2012</xref>) and on the mRNA levels/cell for a large set of genes using digital gene expression technology (Figure 3F; <xref ref-type=""bibr"" rid=""bib5"">Lin et al., 2012</xref>). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published in eLife.",1/26/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:10,e04024,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
XHFNUE84,journalArticle,2015,"Chroscinski, Denise; Maherali, Nimet; Griner, Erin; Reproducibility Project: Cancer Biology",Registered report: The CD47-signal regulated protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors,Biology,eLife,,2050-084X,10.7554/eLife.04586,https://elifesciences.org/articles/04586,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors’ by <xref ref-type=""bibr"" rid=""bib17"">Willingham et al., 2012</xref>, published in PNAS in 2012. The key experiments being replicated are those reported in Figure 6A–C and Table S4. In these experiments, <xref ref-type=""bibr"" rid=""bib17"">Willingham et al., 2012</xref> test the safety and efficacy of anti-CD47 antibody treatment in immune competent mice utilizing a syngeneic model of mammary tumor growth in FVB mice. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published in eLife.",1/26/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:12,e04586,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5PIGEWBM,journalArticle,2015,"Blum, David; Hao, Haiping; McCarthy, Michael; Biology, Reproducibility Project: Cancer",Registered report: Transcriptional amplification in tumor cells with elevated c-Myc,Biology,eLife,,2050-084X,10/gf9h57,https://elifesciences.org/content/4/e04024v1,"<meta name=""DC.Rights"" content=""© 2014, Blum et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.""/> <meta name=""DC.Contributor"" content=""David Blum""/> <meta name=""DC.Contributor"" content=""Haiping Hao""/> <meta name=""DC.Contributor"" content=""Michael McCarthy""/> <meta name=""DC.Contributor"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""DC.Contributor"" content=""Michael R Green""/> <meta name=""DC.Contributor"" content=""Elizabeth Iorns""/> <meta name=""DC.Contributor"" content=""William Gunn""/> <meta name=""DC.Contributor"" content=""Fraser Tan""/> <meta name=""DC.Contributor"" content=""Joelle Lomax""/> <meta name=""DC.Contributor"" content=""Timothy Errington""/> <meta name=""citation_funding_source"" content=""citation_funder=Laura and John Arnold Foundation;citation_grant_number=;citation_grant_recipient= ""/> <meta name=""citation_author"" content=""David Blum""/> <meta name=""citation_author_institution"" content=""Bioexpression and Fermentation Facility""/> <meta name=""citation_author_institution"" content=""University of Georgia""/> <meta name=""citation_author"" content=""Haiping Hao""/> <meta name=""citation_author_institution"" content=""JHMI Deep Sequencing and Microarray Core Facility""/> <meta name=""citation_author_institution"" content=""Johns Hopkins University""/> <meta name=""citation_author"" content=""Michael McCarthy""/> <meta name=""citation_author_institution"" content=""University of Oxford""/> <meta name=""citation_author"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""citation_author_email"" content=""tim@cos.io""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews Cancer;citation_author=GK. Alderton;citation_title=Transcription: the transcriptional effects of MYC;citation_pages=513;citation_volume=14;citation_year=2014;citation_doi=10.1038/nrc3790""/> <meta name=""citation_reference"" content=""citation_journal_title=Cold Spring Harbor Perspectives in Medicine;citation_author=CV. Dang;citation_title=MYC, metabolism, cell growth, and tumorigenesis;citation_pages=a014217;citation_volume=3;citation_year=2013;citation_doi=10.1101/cshperspect.a014217""/> <meta name=""citation_reference"" content=""citation_journal_title=Behavior Research Methods;citation_author=F. Faul;citation_author=E. Erdfelder;citation_author=AG. Lang;citation_author=A. Buchner;citation_title=G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences;citation_pages=175-191;citation_volume=39;citation_year=2007;citation_doi=10.3758/BF03193146""/> <meta name=""citation_reference"" content=""citation_journal_title=Frontiers in Psychology;citation_author=D. Lakens;citation_title=Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs;citation_pages=863;citation_volume=4;citation_year=2013;citation_doi=10.3389/fpsyg.2013.00863""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=CY. Lin;citation_author=J. Lovén;citation_author=PB. Rahl;citation_author=RM. Paranal;citation_author=CB. Burge;citation_author=JE. Bradner;citation_author=TI. Lee;citation_author=RA. Young;citation_title=Transcriptional amplification in tumor cells with elevated c-Myc;citation_pages=56-67;citation_volume=151;citation_year=2012;citation_doi=10.1016/j.cell.2012.08.026""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=Z. Nie;citation_author=G. Hu;citation_author=G. Wei;citation_author=K. Cui;citation_author=A. Yamane;citation_author=W. Resch;citation_author=R. Wang;citation_author=DR. Green;citation_author=L. Tessarollo;citation_author=R. Casellas;citation_author=K. Zhao;citation_author=D. Levens;citation_title=c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells;citation_pages=68-79;citation_volume=151;citation_year=2012;citation_doi=10.1016/j.cell.2012.08.033""/> <meta name=""citation_reference"" content=""citation_journal_title=International Journal of cancer. Journal International Du Cancer;citation_author=A. Pajic;citation_author=D. Spitkovsky;citation_author=B. Christoph;citation_author=B. Kempkes;citation_author=M. Schuhmacher;citation_author=MS. Staege;citation_author=M. Brielmeier;citation_author=J. Ellwart;citation_author=F. Kohlhuber;citation_author=GW. Bornkamm;citation_author=A. Polack;citation_author=D. Eick;citation_title=Cell cycle activation by c-myc in a burkitt lymphoma model cell line;citation_pages=787-793;citation_volume=87;citation_year=2000;citation_doi=10.1002/1097-0215(20000915)87:63.0.CO;2-6""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=A. Sabò;citation_author=TR. Kress;citation_author=M. Pelizzola;citation_author=S. de Pretis;citation_author=MM. Gorski;citation_author=A. Tesi;citation_author=MJ. Morelli;citation_author=P. Bora;citation_author=M. Doni;citation_author=A. Verrecchia;citation_author=C. Tonelli;citation_author=G. Fagà;citation_author=V. Bianchi;citation_author=A. Ronchi;citation_author=D. Low;citation_author=H. Müller;citation_author=E. Guccione;citation_author=S. Campaner;citation_author=B. Amati;citation_title=Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis;citation_pages=488-492;citation_volume=511;citation_year=2014;citation_doi=10.1038/nature13537""/> <meta name=""citation_reference"" content=""citation_journal_title=Oncogene;citation_author=I. Schlosser;citation_author=M. Hölzel;citation_author=R. Hoffmann;citation_author=H. Burtschler;citation_author=F. Kohlhuber;citation_author=M. Schuhmacher;citation_author=R. Chapman;citation_author=UH. Weidle;citation_author=D. Eick;citation_title=Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line;citation_pages=520-524;citation_volume=24;citation_year=2005;citation_doi=10.1038/sj.onc.1208198""/> <meta name=""citation_reference"" content=""citation_journal_title=Current Biology;citation_author=M. Schuhmacher;citation_author=MS. Staege;citation_author=A. Pajic;citation_author=A. Polack;citation_author=UH. Weidle;citation_author=GW. Bornkamm;citation_author=D. Eick;citation_author=F. Kohlhuber;citation_title=Control of cell growth by c-Myc in the absence of cell division;citation_pages=1255-1258;citation_volume=9;citation_year=1999;citation_doi=10.1016/S0960-9822(99)80507-7""/> <meta name=""citation_reference"" content=""citation_journal_title=Transcription;citation_author=M. Schuhmacher;citation_author=D. Eick;citation_title=Dose-dependent regulation of target gene expression and cell proliferation by c-Myc levels;citation_pages=192-197;citation_volume=4;citation_year=2013;citation_doi=10.4161/trns.25907""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=S. Walz;citation_author=F. Lorenzin;citation_author=J. Morton;citation_author=KE. Wiese;citation_author=B. von Eyss;citation_author=S. Herold;citation_author=L. Rycak;citation_author=H. Dumay-Odelot;citation_author=S. Karim;citation_author=M. Bartkuhn;citation_author=F. Roels;citation_author=T. Wüstefeld;citation_author=M. Fischer;citation_author=M. Teichmann;citation_author=L. Zender;citation_author=CL. Wei;citation_author=O. Sansom;citation_author=E. Wolf;citation_author=M. Eilers;citation_title=Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles;citation_pages=483-487;citation_volume=511;citation_year=2014;citation_doi=10.1038/nature13473""/>",1/26/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:39,e04024,,,4,,,Registered report,,,,,,,en,"© 2014, Blum et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.",,,,elifesciences.org,,00000  Citation Key: blum_registered_2015-1 00000  PMID: 25621564,,,,,Human; methodology; Gene expression; reproducibility project: cancer biology; c-Myc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
XZ9JVWV2,journalArticle,2015,"Chroscinski, Denise; Sampey, Darryl; Maherali, Nimet; Reproducibility Project: Cancer Biology",Registered report: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells,Biology,eLife,,2050-084X,10.7554/eLife.04363,https://elifesciences.org/articles/04363,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells’ by Ricci-Vitiani and colleagues, published in Nature in 2010 (<xref ref-type=""bibr"" rid=""bib13"">Ricci-Vitiani et al., 2010</xref>). The experiments that will be replicated are those reported in Figure 4B and Supplementary Figure 10B (<xref ref-type=""bibr"" rid=""bib13"">Ricci-Vitiani et al., 2010</xref>), which demonstrate that glioblastoma stem-like cells can derive into endothelial cells, and can be selectively ablated to reduce tumor progression in vivo, and Supplementary Figures S10C and S10D (<xref ref-type=""bibr"" rid=""bib13"">Ricci-Vitiani et al., 2010</xref>), which demonstrate that fully differentiated glioblastoma cells cannot form functionally relevant endothelium. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",2/25/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:16,e04363,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3SS5DZWS,journalArticle,2015,"Chroscinski, Denise; Sampey, Darryl; Maherali, Nimet; Biology, Reproducibility Project: Cancer",Registered report: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells,Biology,eLife,,2050-084X,10/gf9h56,https://elifesciences.org/content/4/e04363v1,"<meta name=""DC.Rights"" content=""© 2015, Chroscinski et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.""/> <meta name=""DC.Contributor"" content=""Denise Chroscinski""/> <meta name=""DC.Contributor"" content=""Darryl Sampey""/> <meta name=""DC.Contributor"" content=""Nimet Maherali""/> <meta name=""DC.Contributor"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""DC.Contributor"" content=""Hideyuki Okano""/> <meta name=""DC.Contributor"" content=""Elizabeth Iorns""/> <meta name=""DC.Contributor"" content=""William Gunn""/> <meta name=""DC.Contributor"" content=""Fraser Tan""/> <meta name=""DC.Contributor"" content=""Joelle Lomax""/> <meta name=""DC.Contributor"" content=""Timothy Errington""/> <meta name=""citation_funding_source"" content=""citation_funder=Laura and John Arnold Foundation;citation_grant_number=;citation_grant_recipient= ""/> <meta name=""citation_author"" content=""Denise Chroscinski""/> <meta name=""citation_author_institution"" content=""Noble Life Sciences""/> <meta name=""citation_author"" content=""Darryl Sampey""/> <meta name=""citation_author_institution"" content=""BioFactura""/> <meta name=""citation_author"" content=""Nimet Maherali""/> <meta name=""citation_author_institution"" content=""Harvard Stem Cell Institute""/> <meta name=""citation_author"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""citation_author_email"" content=""joelle@scienceexchange.com""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=L. Cheng;citation_author=Z. Huang;citation_author=W. Zhou;citation_author=Q. Wu;citation_author=S. Donnola;citation_author=JK. Liu;citation_author=X. Fang;citation_author=AE. Sloan;citation_author=Y. Mao;citation_author=JD. Lathia;citation_author=W. Min;citation_author=RE. McLendon;citation_author=JN. Rich;citation_author=S. Bao;citation_title=Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth;citation_pages=139-152;citation_volume=153;citation_year=2013;citation_doi=10.1016/j.cell.2013.02.021""/> <meta name=""citation_reference"" content=""citation_journal_title=Current Neurovascular Research;citation_author=MT. Chiao;citation_author=YC. Yang;citation_author=WY. Cheng;citation_author=CC. Shen;citation_author=JL. Ko;citation_title=CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo;citation_pages=210-219;citation_volume=8;citation_year=2011;citation_doi=10.2174/156720211796558023""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Cell;citation_author=M. De Palma;citation_author=MA. Venneri;citation_author=R. Galli;citation_author=L. Sergi Sergi;citation_author=LS. Politi;citation_author=M. Sampaolesi;citation_author=L. Naldini;citation_title=Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors;citation_pages=211-226;citation_volume=8;citation_year=2005;citation_doi=10.1016/j.ccr.2005.08.002""/> <meta name=""citation_reference"" content=""citation_journal_title=Brain;citation_author=S. El Hallani;citation_author=B. Boisselier;citation_author=F. Peglion;citation_author=A. Rousseau;citation_author=C. Colin;citation_author=A. Idbaih;citation_author=Y. Marie;citation_author=K. Mokhtari;citation_author=JL. Thomas;citation_author=A. Eichmann;citation_author=JY. Delattre;citation_author=AJ. Maniotis;citation_author=M. Sanson;citation_title=A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry;citation_pages=973-982;citation_volume=133;citation_year=2010;citation_doi=10.1093/brain/awq044""/> <meta name=""citation_reference"" content=""citation_journal_title=BioMed Research International;citation_author=S. El Hallani;citation_author=C. Colin;citation_author=Y. El Houfi;citation_author=A. Idbaih;citation_author=B. Boisselier;citation_author=Y. Marie;citation_author=P. Ravassard;citation_author=M. Labussière;citation_author=K. Mokhtari;citation_author=JL. Thomas;citation_author=JY. Delattre;citation_author=A. Eichmann;citation_author=M. Sanson;citation_title=Tumor and endothelial cell hybrids participate in glioblastoma vasculature;citation_pages=827327;citation_volume=2014;citation_year=2014;citation_doi=10.1155/2014/827327""/> <meta name=""citation_reference"" content=""citation_journal_title=Oncology Letters;citation_author=YL. Fan;citation_author=M. Zheng;citation_author=YL. Tang;citation_author=XH. Liang;citation_title=A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review);citation_pages=1174-1180;citation_volume=6;citation_year=2013;citation_doi=10.3892/ol.2013.1555""/> <meta name=""citation_reference"" content=""citation_journal_title=Behavior Research Methods;citation_author=F. Faul;citation_author=E. Erdfelder;citation_author=AG. Lang;citation_author=A. Buchner;citation_title=G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences;citation_pages=175-191;citation_volume=39;citation_year=2007;citation_doi=10.3758/BF03193146""/> <meta name=""citation_reference"" content=""citation_journal_title=BMC Cancer;citation_author=A. Ghanekar;citation_author=S. Ahmed;citation_author=K. Chen;citation_author=O. Adeyi;citation_title=Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma;citation_pages=485;citation_volume=13;citation_year=2013;citation_doi=10.1186/1471-2407-13-485""/> <meta name=""citation_reference"" content=""citation_journal_title=Clinical &amp; Translational Oncology;citation_author=S. Kaur;citation_author=P. Bajwa;citation_title=A ‘tête-à tête’ between cancer stem cells and endothelial progenitor cells in tumor angiogenesis;citation_pages=115-121;citation_volume=16;citation_year=2014;citation_doi=10.1007/s12094-013-1103-4""/> <meta name=""citation_reference"" content=""citation_journal_title=Frontiers in Psychology;citation_author=D. Lakens;citation_title=Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs;citation_pages=863;citation_volume=4;citation_year=2013;citation_doi=10.3389/fpsyg.2013.00863""/> <meta name=""citation_reference"" content=""citation_journal_title=PLoS ONE;citation_author=JD. Lathia;citation_author=J. Gallagher;citation_author=JT. Myers;citation_author=M. Li;citation_author=A. Vasanji;citation_author=RE. McLendon;citation_author=AB. Hjelmeland;citation_author=AY. Huang;citation_author=JN. Rich;citation_title=Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells;citation_pages=e24807;citation_volume=6;citation_year=2011;citation_doi=10.1371/journal.pone.0024807""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=S. Purhonen;citation_author=J. Palm;citation_author=D. Rossi;citation_author=N. Kaskenpaa;citation_author=I. Rajantie;citation_author=S. Yla-Herttuala;citation_author=K. Alitalo;citation_author=IL. Weissman;citation_author=P. Salven;citation_title=Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth;citation_pages=6620-6625;citation_volume=105;citation_year=2008;citation_doi=10.1073/pnas.0710516105""/> <meta name=""citation_reference"" content=""citation_author=R Development Core Team;citation_title=R: A language and environment for statistical computing;citation_title=R Foundation for Statistical Computing;citation_year=2014""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=L. Ricci-Vitiani;citation_author=R. Pallini;citation_author=M. Biffoni;citation_author=M. Todaro;citation_author=G. Invernici;citation_author=T. Cenci;citation_author=G. Maira;citation_author=EA. Parati;citation_author=G. Stassi;citation_author=LM. Larocca;citation_author=R. De Maria;citation_title=Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells;citation_pages=824-828;citation_volume=468;citation_year=2010;citation_doi=10.1038/nature09557""/> <meta name=""citation_reference"" content=""citation_journal_title=Oncotarget;citation_author=FJ. Rodriguez;citation_author=BA. Orr;citation_author=KL. Ligon;citation_author=CG. Eberhart;citation_title=Neoplastic cells are a rare component in human glioblastoma microvasculature;citation_pages=98-106;citation_volume=3;citation_year=2012""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=Y. Soda;citation_author=T. Marumoto;citation_author=D. Friedmann-Morvinski;citation_author=M. Soda;citation_author=F. Liu;citation_author=H. Michiue;citation_author=S. Pastorino;citation_author=M. Yang;citation_author=RM. Hoffman;citation_author=S. Kesari;citation_author=IM. Verma;citation_title=Transdifferentiation of glioblastoma cells into vascular endothelial cells;citation_pages=4274-4280;citation_volume=108;citation_year=2011;citation_doi=10.1073/pnas.1016030108""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews Cancer;citation_author=AL. Vescovi;citation_author=R. Galli;citation_author=BA. Reynolds;citation_title=Brain tumour stem cells;citation_pages=425-436;citation_volume=6;citation_year=2006;citation_doi=10.1038/nrc1889""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=R. Wang;citation_author=K. Chadalavada;citation_author=J. Wilshire;citation_author=U. Kowalik;citation_author=KE. Hovinga;citation_author=A. Geber;citation_author=B. Fligelman;citation_author=M. Leversha;citation_author=C. Brennan;citation_author=V. Tabar;citation_title=Glioblastoma stem-like cells give rise to tumour endothelium;citation_pages=829-833;citation_volume=468;citation_year=2010;citation_doi=10.1038/nature09624""/>",2/25/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:41,e04363,,,4,,,Registered report,,,,,,,en,"© 2015, Chroscinski et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.",,,,elifesciences.org,,00000  Citation Key: chroscinski_registered_2015-1 00000  PMID: 25714925,,,,,methodology; Mouse; reproducibility project: cancer biology; cancer stem cell; endothelium; glioblastoma multiforme,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGKMDQWD,journalArticle,2015,"Incardona, Francesca; Doroudchi, M Mehdi; Ismail, Nawfal; Carreno, Alberto; Griner, Erin; Anna Lim, Minyoung; Reproducibility Project: Cancer Biology",Registered report: Interactions between cancer stem cells and their niche govern metastatic colonization,Biology,eLife,,2050-084X,10.7554/eLife.06938,https://elifesciences.org/articles/06938,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by replicating selected results from a substantial number of high-profile papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Interactions between cancer stem cells and their niche govern metastatic colonization’ by Malanchi and colleagues, published in Nature in 2012 (<xref ref-type=""bibr"" rid=""bib10"">Malanchi et al., 2012</xref>). The key experiments that will be replicated are those reported in Figures 2H, 3A, 3B, and S13. In these experiments, Malanchi and colleagues analyze messenger RNA levels of periostin (POSTN) in pulmonary fibroblasts, endothelial cells, and immune cells isolated from mice with micrometastases to determine which cell type is producing POSTN in the metastatic niche (Figure 2H; <xref ref-type=""bibr"" rid=""bib10"">Malanchi et al., 2012</xref>). Additionally, they examine MMTV-PyMT control or POSTN null mice to test the effect of POSTN on primary tumor growth and metastasis (Figures 3A, 3B, and S13; <xref ref-type=""bibr"" rid=""bib10"">Malanchi et al., 2012</xref>). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published in eLife.",6/18/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:19,e06938,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4C8TIKIQ,journalArticle,2015,"Kandela, Irawati; Jin, Hyun Yong; Owen, Katherine; Biology, Reproducibility Project: Cancer",Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc,Biology,eLife,,2050-084X,10/gf9h5z,https://elifesciences.org/content/4/e07072v1,"<meta name=""DC.Rights"" content=""© 2015, Kandela et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.""/> <meta name=""DC.Contributor"" content=""Irawati Kandela""/> <meta name=""DC.Contributor"" content=""Hyun Yong Jin""/> <meta name=""DC.Contributor"" content=""Katherine Owen""/> <meta name=""DC.Contributor"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""DC.Contributor"" content=""Christopher Glass""/> <meta name=""DC.Contributor"" content=""Elizabeth Iorns""/> <meta name=""DC.Contributor"" content=""William Gunn""/> <meta name=""DC.Contributor"" content=""Fraser Tan""/> <meta name=""DC.Contributor"" content=""Joelle Lomax""/> <meta name=""DC.Contributor"" content=""Nicole Perfito""/> <meta name=""DC.Contributor"" content=""Timothy Errington""/> <meta name=""citation_funding_source"" content=""citation_funder=Laura and John Arnold Foundation;citation_grant_number=;citation_grant_recipient= ""/> <meta name=""citation_author"" content=""Irawati Kandela""/> <meta name=""citation_author_institution"" content=""Developmental Therapeutics Core""/> <meta name=""citation_author_institution"" content=""Northwestern University""/> <meta name=""citation_author"" content=""Hyun Yong Jin""/> <meta name=""citation_author_institution"" content=""The Scripps Research Institute""/> <meta name=""citation_author"" content=""Katherine Owen""/> <meta name=""citation_author_institution"" content=""University of Virginia""/> <meta name=""citation_author"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""citation_author_email"" content=""tim@cos.io""/> <meta name=""citation_reference"" content=""citation_journal_title=Oncology;citation_author=KC. Anderson;citation_title=The future of treatment for patients with relapsed/refractory multiple myeloma;citation_pages=2;citation_volume=25;citation_year=2011""/> <meta name=""citation_reference"" content=""citation_journal_title=Journal of the National Comprehensive Cancer Network;citation_author=KC. Anderson;citation_author=M. Alsina;citation_author=W. Bensinger;citation_author=JS. Biermann;citation_author=A. Chanan-Khan;citation_author=AD. Cohen;citation_author=S. Devine;citation_author=B. Djulbegovic;citation_author=EA. Faber Jr;citation_author=C. Gasparetto;citation_author=CA. Huff;citation_author=A. Kassim;citation_author=BC. Medeiros;citation_author=R. Meredith;citation_author=N. Raje;citation_author=J. Schriber;citation_author=S. Singhal;citation_author=G. Somlo;citation_author=K. Stockerl-Goldstein;citation_author=SP. Treon;citation_author=G. Tricot;citation_author=DM. Weber;citation_author=J. Yahalom;citation_author=F. Yunus;citation_title=Multiple myeloma;citation_pages=1146-1183;citation_volume=9;citation_year=2011""/> <meta name=""citation_reference"" content=""citation_journal_title=Journal of Clinical Oncology;citation_author=PL. Bergsagel;citation_author=WM. Kuehl;citation_title=Molecular pathogenesis and a consequent classification of multiple myeloma;citation_pages=6333-6338;citation_volume=23;citation_year=2005;citation_doi=10.1200/JCO.2005.05.021""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=DA. Bisgrove;citation_author=T. Mahmoudi;citation_author=P. Henklein;citation_author=E. Verdin;citation_title=Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription;citation_pages=13690-13695;citation_volume=104;citation_year=2007;citation_doi=10.1073/pnas.0705053104""/> <meta name=""citation_reference"" content=""citation_journal_title=Leukemia;citation_author=WJ. Chng;citation_author=GF. Huang;citation_author=TH. Chung;citation_author=SB. Ng;citation_author=N. Gonzalez-Paz;citation_author=T. Troska-Price;citation_author=G. Mulligan;citation_author=M. Chesi;citation_author=PL. Bergsagel;citation_author=R. Fonseca;citation_title=Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma;citation_pages=1026-1035;citation_volume=25;citation_year=2011;citation_doi=10.1038/leu.2011.53""/> <meta name=""citation_reference"" content=""citation_journal_title=Understanding Statistics;citation_author=BH. Cohen;citation_title=Calculating a factorial ANOVA from means and standard deviations;citation_pages=191-203;citation_volume=1;citation_year=2002;citation_doi=10.1207/S15328031US0103_04""/> <meta name=""citation_reference"" content=""citation_journal_title=Cold Spring Harbor Perspectives in Medicine;citation_author=M. Conacci-Sorrell;citation_author=L. McFerrin;citation_author=RN. Eisenman;citation_title=An overview of MYC and its interactome;citation_pages=a014357;citation_volume=4;citation_year=2014;citation_doi=10.1101/cshperspect.a014357""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews. Cancer;citation_author=JE. Darnell Jr;citation_title=Transcription factors as targets for cancer therapy;citation_pages=740-749;citation_volume=2;citation_year=2002;citation_doi=10.1038/nrc906""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=JE. Delmore;citation_author=GC. Issa;citation_author=ME. Lemieux;citation_author=PB. Rahl;citation_author=J. Shi;citation_author=HM. Jacobs;citation_author=E. Kastritis;citation_author=T. Gilpatrick;citation_author=RM. Paranal;citation_author=J. Qi;citation_author=M. Chesi;citation_author=AC. Schinzel;citation_author=MR. McKeown;citation_author=TP. Heffernan;citation_author=CR. Vakoc;citation_author=PL. Bergsagel;citation_author=IM. Ghobrial;citation_author=PG. Richardson;citation_author=RA. Young;citation_author=WC. Hahn;citation_author=KC. Anderson;citation_author=AL. Kung;citation_author=JE. Bradner;citation_author=CS. Mitsiades;citation_title=BET bromodomain inhibition as a therapeutic strategy to target c-Myc;citation_pages=904-917;citation_volume=146;citation_year=2011;citation_doi=10.1016/j.cell.2011.08.017""/> <meta name=""citation_reference"" content=""citation_journal_title=Molecular Biology of the Cell;citation_author=A. Dey;citation_author=A. Nishiyama;citation_author=T. Karpova;citation_author=J. McNally;citation_author=K. Ozato;citation_title=Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription;citation_pages=4899-4909;citation_volume=20;citation_year=2009;citation_doi=10.1091/mbc.E09-05-0380""/> <meta name=""citation_reference"" content=""citation_journal_title=Behavior Research Methods;citation_author=F. Faul;citation_author=E. Erdfelder;citation_author=AG. Lang;citation_author=A. Buchner;citation_title=G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences;citation_pages=175-191;citation_volume=39;citation_year=2007;citation_doi=10.3758/BF03193146""/> <meta name=""citation_reference"" content=""citation_journal_title=Molecular Cell;citation_author=DW. Felsher;citation_author=JM. Bishop;citation_title=Reversible tumorigenesis by MYC in hematopoietic lineages;citation_pages=199-207;citation_volume=4;citation_year=1999;citation_doi=10.1016/S1097-2765(00)80367-6""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=P. Filippakopoulos;citation_author=J. Qi;citation_author=S. Picaud;citation_author=Y. Shen;citation_author=WB. Smith;citation_author=O. Fedorov;citation_author=EM. Morse;citation_author=T. Keates;citation_author=TT. Hickman;citation_author=I. Felletar;citation_author=M. Philpott;citation_author=S. Munro;citation_author=MR. McKeown;citation_author=Y. Wang;citation_author=AL. Christie;citation_author=N. West;citation_author=MJ. Cameron;citation_author=B. Schwartz;citation_author=TD. Heightman;citation_author=N. La Thangue;citation_author=CA. French;citation_author=O. Wiest;citation_author=AL. Kung;citation_author=S. Knapp;citation_author=JE. Bradner;citation_title=Selective inhibition of BET bromodomains;citation_pages=1067-1073;citation_volume=468;citation_year=2010;citation_doi=10.1038/nature09504""/> <meta name=""citation_reference"" content=""citation_journal_title=Oncogene;citation_author=I. Flores;citation_author=DJ. Murphy;citation_author=LB. Swigart;citation_author=U. Knies;citation_author=GI. Evan;citation_title=Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia;citation_pages=5923-5930;citation_volume=23;citation_year=2004;citation_doi=10.1038/sj.onc.1207796""/> <meta name=""citation_reference"" content=""citation_journal_title=Cold Spring Harbor Perspectives in Medicine;citation_author=M. Gabay;citation_author=Y. Li;citation_author=DW. Felsher;citation_title=MYC activation is a hallmark of cancer initiation and maintenance;citation_pages=a014241;citation_volume=4;citation_year=2014;citation_doi=10.1101/cshperspect.a014241""/> <meta name=""citation_reference"" content=""citation_journal_title=Stem Cells and Development;citation_author=G. Horne;citation_author=H. Stewart;citation_author=J. Dickson;citation_author=S. Knapp;citation_author=B. Ramsahoye;citation_author=T. Chevassut;citation_title=Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1;citation_pages=879-891;citation_volume=24;citation_year=2014;citation_doi=10.1089/scd.2014.0302""/> <meta name=""citation_reference"" content=""citation_journal_title=Leukemia;citation_author=SK. Kumar;citation_author=JH. Lee;citation_author=JJ. Lahuerta;citation_author=G. Morgan;citation_author=PG. Richardson;citation_author=J. Crowley;citation_author=J. Haessler;citation_author=J. Feather;citation_author=A. Hoering;citation_author=P. Moreau;citation_author=X. LeLeu;citation_author=C. Hulin;citation_author=SK. Klein;citation_author=P. Sonneveld;citation_author=D. Siegel;citation_author=J. Blade;citation_author=H. Goldschmidt;citation_author=S. Jagannath;citation_author=JS. Miguel;citation_author=R. Orlowski;citation_author=A. Palumbo;citation_author=O. Sezer;citation_author=SV. Rajkumar;citation_author=BG. Durie;citation_author=International Myeloma Working Group;citation_title=Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study;citation_pages=149-157;citation_volume=26;citation_year=2012;citation_doi=10.1038/leu.2011.196""/> <meta name=""citation_reference"" content=""citation_journal_title=Frontiers in psychology;citation_author=D. Lakens;citation_title=Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs;citation_pages=863;citation_volume=4;citation_year=2013;citation_doi=10.3389/fpsyg.2013.00863""/> <meta name=""citation_reference"" content=""citation_journal_title=Molecular Cell;citation_author=G. LeRoy;citation_author=B. Rickards;citation_author=SJ. Flint;citation_title=The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription;citation_pages=51-60;citation_volume=30;citation_year=2008;citation_doi=10.1016/j.molcel.2008.01.018""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=WW. Lockwood;citation_author=K. Zejnullahu;citation_author=JE. Bradner;citation_author=H. Varmus;citation_title=Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins;citation_pages=19408-19413;citation_volume=109;citation_year=2012;citation_doi=10.1073/pnas.1216363109""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=J. Loven;citation_author=HA. Hoke;citation_author=CY. Lin;citation_author=A. Lau;citation_author=DA. Orlando;citation_author=CR. Vakoc;citation_author=JE. Bradner;citation_author=TI. Lee;citation_author=RA. Young;citation_title=Selective inhibition of tumor oncogenes by disruption of super-enhancers;citation_pages=320-334;citation_volume=153;citation_year=2013;citation_doi=10.1016/j.cell.2013.03.036""/> <meta name=""citation_reference"" content=""citation_journal_title=Cold Spring Harbor Perspectives in Medicine;citation_author=MR. McKeown;citation_author=JE. Bradner;citation_title=Therapeutic strategies to inhibit MYC;citation_pages=a014266;citation_volume=4;citation_year=2014;citation_doi=10.1101/cshperspect.a014266""/> <meta name=""citation_reference"" content=""citation_journal_title=Proceedings of the National Academy of Sciences of USA;citation_author=JA. Mertz;citation_author=AR. Conery;citation_author=BM. Bryant;citation_author=P. Sandy;citation_author=S. Balasubramanian;citation_author=DA. Mele;citation_author=L. Bergeron;citation_author=RJ. Sims III;citation_title=Targeting MYC dependence in cancer by inhibiting BET bromodomains;citation_pages=16669-16674;citation_volume=108;citation_year=2011;citation_doi=10.1073/pnas.1108190108""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews. Cancer;citation_author=N. Meyer;citation_author=LZ. Penn;citation_title=Reflecting on 25 years with MYC;citation_pages=976-990;citation_volume=8;citation_year=2008;citation_doi=10.1038/nrc2231""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews. Cancer;citation_author=GJ. Morgan;citation_author=BA. Walker;citation_author=FE. Davies;citation_title=The genetic architecture of multiple myeloma;citation_pages=335-348;citation_volume=12;citation_year=2012;citation_doi=10.1038/nrc3257""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=E. Nicodeme;citation_author=KL. Jeffrey;citation_author=U. Schaefer;citation_author=S. Beinke;citation_author=S. Dewell;citation_author=CW. Chung;citation_author=R. Chandwani;citation_author=I. Marazzi;citation_author=P. Wilson;citation_author=H. Coste;citation_author=J. White;citation_author=J. Kirilovsky;citation_author=CM. Rice;citation_author=JM. Lora;citation_author=RK. Prinjha;citation_author=K. Lee;citation_author=A. Tarakhovsky;citation_title=Suppression of inflammation by a synthetic histone mimic;citation_pages=1119-1123;citation_volume=468;citation_year=2010;citation_doi=10.1038/nature09589""/> <meta name=""citation_reference"" content=""citation_journal_title=Blood;citation_author=CJ. Ott;citation_author=N. Kopp;citation_author=L. Bird;citation_author=RM. Paranal;citation_author=J. Qi;citation_author=T. Bowman;citation_author=SJ. Rodig;citation_author=AL. Kung;citation_author=JE. Bradner;citation_author=DM. Weinstock;citation_title=BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia;citation_pages=2843-2852;citation_volume=120;citation_year=2012;citation_doi=10.1182/blood-2012-02-413021""/> <meta name=""citation_reference"" content=""citation_journal_title=Biometrics;citation_author=DA. Schoenfeld;citation_title=Sample-size formula for the proportional-hazards regression model;citation_pages=499-503;citation_volume=39;citation_year=1983;citation_doi=10.2307/2531021""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Research;citation_author=Q. Shao;citation_author=A. Kannan;citation_author=Z. Lin;citation_author=BC. Stack Jr;citation_author=JY. Suen;citation_author=L. Gao;citation_title=BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo;citation_pages=7090-7102;citation_volume=74;citation_year=2014;citation_doi=10.1158/0008-5472.CAN-14-0305""/> <meta name=""citation_reference"" content=""citation_journal_title=Clinical Cancer Research;citation_author=T. Shimamura;citation_author=Z. Chen;citation_author=M. Soucheray;citation_author=J. Carretero;citation_author=E. Kikuchi;citation_author=JH. Tchaicha;citation_author=Y. Gao;citation_author=KA. Cheng;citation_author=TJ. Cohoon;citation_author=J. Qi;citation_author=E. Akbay;citation_author=AC. Kimmelman;citation_author=AL. Kung;citation_author=JE. Bradner;citation_author=KK. Wong;citation_title=Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer;citation_pages=6183-6192;citation_volume=19;citation_year=2013;citation_doi=10.1158/1078-0432.CCR-12-3904""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=L. Soucek;citation_author=J. Whitfield;citation_author=CP. Martins;citation_author=AJ. Finch;citation_author=DJ. Murphy;citation_author=NM. Sodir;citation_author=AN. Karnezis;citation_author=LB. Swigart;citation_author=S. Nasi;citation_author=GI. Evan;citation_title=Modelling Myc inhibition as a cancer therapy;citation_pages=679-683;citation_volume=455;citation_year=2008;citation_doi=10.1038/nature07260""/> <meta name=""citation_reference"" content=""citation_author=Team RC;citation_title=R: a language and environment for statistical computing;citation_year=2014""/> <meta name=""citation_reference"" content=""citation_journal_title=Oncogene;citation_author=B. Tolani;citation_author=R. Gopalakrishnan;citation_author=V. Punj;citation_author=H. Matta;citation_author=PM. Chaudhary;citation_title=Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors;citation_pages=2928-2937;citation_volume=33;citation_year=2014;citation_doi=10.1038/onc.2013.242""/> <meta name=""citation_reference"" content=""citation_journal_title=Clinical Cancer Research;citation_author=SE. Trabucco;citation_author=RM. Gerstein;citation_author=AM. Evens;citation_author=JE. Bradner;citation_author=LD. Shultz;citation_author=DL. Greiner;citation_author=H. Zhang;citation_title=Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma;citation_pages=113-122;citation_volume=21;citation_year=2015;citation_doi=10.1158/1078-0432.CCR-13-3346""/> <meta name=""citation_reference"" content=""citation_journal_title=The Journal of Biological Chemistry;citation_author=SY. Wu;citation_author=CM. Chiang;citation_title=The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation;citation_pages=13141-13145;citation_volume=282;citation_year=2007;citation_doi=10.1074/jbc.R700001200""/>",6/25/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:41,e07072,,,4,,,Registered report,,,,,,,en,"© 2015, Kandela et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.",,,,elifesciences.org,,00000  Citation Key: kandela_registered_2015 00000  PMID: 26111384,,,,,Human; methodology; Mouse; bromodomain inhibitor; myeloma; reproducibility project: cancer biology; targeted therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CRM6QDFU,journalArticle,2015,"Evans, Brad; Griner, Erin",Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases,Biology,eLife,,2050-084X,10/gf9h5v,http://elifesciences.org/lookup/doi/10.7554/eLife.07420,,7/31/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 19:08,,,,4,,,Registered report,,,,,,,en,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5464F3IQ,journalArticle,2015,"Fung, Juan José; Kosaka, Alan; Shan, Xiaochuan; Danet-Desnoyers, Gwenn; Gormally, Michael; Owen, Kate",Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia,Biology,eLife,,2050-084X,10/gf9h5s,http://elifesciences.org/lookup/doi/10.7554/eLife.08997,,9/1/2015,10/18/2020 17:37,10/18/2020 17:37,5/22/2017 18:08,,,,4,,,Registered report,,,,,,,en,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EJ7SIM6J,journalArticle,2015,"Kandela, Irawati; Jin, Hyun Yong; Owen, Katherine; Reproducibility Project: Cancer Biology",Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc,Biology,eLife,,2050-084X,10.7554/eLife.07072,https://elifesciences.org/articles/07072,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by replicating selected results from a substantial number of high-profile papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘BET bromodomain inhibition as a therapeutic strategy to target c-Myc’ by Delmore and colleagues, published in Cell in 2011 (<xref ref-type=""bibr"" rid=""bib9"">Delmore et al., 2011</xref>). The key experiments that will be replicated are those reported in Figures 3B and 7C-E. Delmore and colleagues demonstrated that treatment with JQ1, a small molecular inhibitor targeting BET bromodomains, resulted in the transcriptional down-regulation of the c-Myc oncogene in vitro (Figure 3B; <xref ref-type=""bibr"" rid=""bib9"">Delmore et al., 2011</xref>). To assess the therapeutic efficacy of JQ1 in vivo, mice bearing multiple myeloma (MM) lesions were treated with JQ1 before evaluation for tumor burden and overall survival. JQ1 treatment significantly reduced disease burden and increased survival time (Figure 7C-E; <xref ref-type=""bibr"" rid=""bib9"">Delmore et al., 2011</xref>). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published in eLife.",6/25/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:20,e07072,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FM2HGNB7,journalArticle,2015,"Fiering, Steven; Ang, Lay-Hong; Lacoste, Judith; Smith, Tim D; Griner, Erin; Reproducibility Project: Cancer Biology",Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis,Biology,eLife,,2050-084X,10.7554/eLife.04796,https://elifesciences.org/articles/04796,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replicating selected results from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012 were selected on the basis of citations and Altimetric scores (<xref ref-type=""bibr"" rid=""bib5a"">Errington et al., 2014</xref>). This Registered report describes the proposed replication plan of key experiments from ‘Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis’ by Goetz and colleagues, published in Cell in 2011 (<xref ref-type=""bibr"" rid=""bib8"">Goetz et al., 2011</xref>). The key experiments being replicated are those reported in Figures 7C (a-d), Supplemental Figure S2A, and Supplemental Figure S7C (a-c) (<xref ref-type=""bibr"" rid=""bib8"">Goetz et al., 2011</xref>). In these experiments, which are a subset of all the experiments reported in the original publication, Goetz and colleagues show in a subcutaneous xenograft model that stromal caveolin-1 remodels the intratumoral microenvironment, which is correlated with increased metastasis formation. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published in eLife.",7/16/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:18,e04796,,,4,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CC3PGF9X,journalArticle,2015,"Fiering, Steven; Ang, Lay-Hong; Lacoste, Judith; Smith, Tim D.; Griner, Erin; Biology, Reproducibility Project: Cancer",Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis,Biology,eLife,,2050-084X,10/gf9h5x,https://elifesciences.org/content/4/e04796v1,"<meta name=""DC.Rights"" content=""© 2015, Fiering et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.""/> <meta name=""DC.Contributor"" content=""Steven Fiering""/> <meta name=""DC.Contributor"" content=""Lay-Hong Ang""/> <meta name=""DC.Contributor"" content=""Judith Lacoste""/> <meta name=""DC.Contributor"" content=""Tim D Smith""/> <meta name=""DC.Contributor"" content=""Erin Griner""/> <meta name=""DC.Contributor"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""DC.Contributor"" content=""Ewa Paluch""/> <meta name=""DC.Contributor"" content=""Elizabeth Iorns""/> <meta name=""DC.Contributor"" content=""William Gunn""/> <meta name=""DC.Contributor"" content=""Fraser Tan""/> <meta name=""DC.Contributor"" content=""Joelle Lomax""/> <meta name=""DC.Contributor"" content=""Timothy Errington""/> <meta name=""citation_funding_source"" content=""citation_funder=Laura and John Arnold Foundation;citation_grant_number=;citation_grant_recipient= ""/> <meta name=""citation_author"" content=""Steven Fiering""/> <meta name=""citation_author_institution"" content=""Transgenics and Genetic Constructs Shared Resource Center""/> <meta name=""citation_author_institution"" content=""Dartmouth University""/> <meta name=""citation_author"" content=""Lay-Hong Ang""/> <meta name=""citation_author_institution"" content=""Confocal Imaging Core""/> <meta name=""citation_author_institution"" content=""Harvard Medical School""/> <meta name=""citation_author"" content=""Judith Lacoste""/> <meta name=""citation_author_institution"" content=""MIA Cellavie Inc.""/> <meta name=""citation_author"" content=""Tim D Smith""/> <meta name=""citation_author_institution"" content=""University of California, Irvine""/> <meta name=""citation_author"" content=""Erin Griner""/> <meta name=""citation_author_institution"" content=""University of Virginia""/> <meta name=""citation_author"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""citation_author_email"" content=""tim@cos.io""/> <meta name=""citation_reference"" content=""citation_journal_title=The American Journal of Pathology;citation_author=MD. Amatangelo;citation_author=DE. Bassi;citation_author=AJ. Klein-Szanto;citation_author=E. Cukierman;citation_title=Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts;citation_pages=475-488;citation_volume=167;citation_year=2005;citation_doi=10.1016/S0002-9440(10)62991-4""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Research;citation_author=F. Capozza;citation_author=C. Trimmer;citation_author=R. Castello-Cros;citation_author=S. Katiyar;citation_author=D. Whitaker-Menezes;citation_author=A. Follenzi;citation_author=M. Crosariol;citation_author=G. Llaverias;citation_author=F. Sotgia;citation_author=RG. Pestell;citation_author=MP. Lisanti;citation_title=Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration;citation_pages=2262-2274;citation_volume=72;citation_year=2012;citation_doi=10.1158/0008-5472.CAN-11-2593""/> <meta name=""citation_reference"" content=""citation_journal_title=Molecular and Cellular Biology;citation_author=A. Cerezo;citation_author=MC. Guadamillas;citation_author=JG. Goetz;citation_author=S. Sanchez-Perales;citation_author=E. Klein;citation_author=RK. Assoian;citation_author=MA. del Pozo;citation_title=The absence of caveolin-1 increases proliferation and anchorage- independent growth by a Rac-dependent, Erk-independent mechanism;citation_pages=5046-5059;citation_volume=29;citation_year=2009;citation_doi=10.1128/MCB.00315-09""/> <meta name=""citation_reference"" content=""citation_journal_title=The American Journal of Pathology;citation_author=SH. Chang;citation_author=D. Feng;citation_author=JA. Nagy;citation_author=TE. Sciuto;citation_author=AM. Dvorak;citation_author=HF. Dvorak;citation_title=Vascular permeability and pathological angiogenesis in caveolin-1-null mice;citation_pages=1768-1776;citation_volume=175;citation_year=2009;citation_doi=10.2353/ajpath.2009.090171""/> <meta name=""citation_reference"" content=""citation_journal_title=American Journal of Cancer Research;citation_author=P. Cirri;citation_author=P. Chiarugi;citation_title=Cancer associated fibroblasts: the dark side of the coin;citation_pages=482-497;citation_volume=1;citation_year=2011""/> <meta name=""citation_reference"" content=""citation_journal_title=eLife;citation_author=TM. Errington;citation_author=E. Iorns;citation_author=W. Gunn;citation_author=FE. Tan;citation_author=J. Lomax;citation_author=BA. Nosek;citation_title=An open investigation of the reproducibility of cancer biology research;citation_pages=e04333;citation_volume=3;citation_year=2014;citation_doi=10.7554/eLife.04333""/> <meta name=""citation_reference"" content=""citation_journal_title=Behavior Research Methods;citation_author=F. Faul;citation_author=E. Erdfelder;citation_author=AG. Lang;citation_author=A. Buchner;citation_title=G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences;citation_pages=175-191;citation_volume=39;citation_year=2007;citation_doi=10.3758/BF03193146""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Metastasis Reviews;citation_author=JG. Goetz;citation_author=P. Lajoie;citation_author=SM. Wiseman;citation_author=IR. Nabi;citation_title=Caveolin-1 in tumor progression: the good, the bad and the ugly;citation_pages=715-735;citation_volume=27;citation_year=2008;citation_doi=10.1007/s10555-008-9160-9""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=JG. Goetz;citation_author=S. Minguet;citation_author=I. Navarro-Lerida;citation_author=JJ. Lazcano;citation_author=R. Samaniego;citation_author=E. Calvo;citation_author=M. Tello;citation_author=T. Osteso-Ibanez;citation_author=T. Pellinen;citation_author=A. Echarri;citation_author=A. Cerezo;citation_author=AJ. Klein-Szanto;citation_author=R. Garcia;citation_author=PJ. Keely;citation_author=P. Sanchez-Mateos;citation_author=E. Cukierman;citation_author=MA. Del Pozo;citation_title=Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis;citation_pages=148-163;citation_volume=146;citation_year=2011;citation_doi=10.1016/j.cell.2011.05.040""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews. Cancer;citation_author=R. Kalluri;citation_author=M. Zeisberg;citation_title=Fibroblasts in cancer;citation_pages=392-401;citation_volume=6;citation_year=2006;citation_doi=10.1038/nrc1877""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=T. Kamijo;citation_author=F. Zindy;citation_author=MF. Roussel;citation_author=DE. Quelle;citation_author=JR. Downing;citation_author=RA. Ashmun;citation_author=G. Grosveld;citation_author=CJ. Sherr;citation_title=Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF;citation_pages=649-659;citation_volume=91;citation_year=1997;citation_doi=10.1016/S0092-8674(00)80452-3""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Research;citation_author=SP. Linke;citation_author=S. Krajewski;citation_author=TM. Bremer;citation_author=AK. Man;citation_author=N. Zeps;citation_author=L. Spalding;citation_title=Abstract P3-10-42: stromal caveolin-1 is a powerful marker that further enhances a multi-marker prognostic profile;citation_volume=70;citation_year=2010;citation_doi=10.1158/0008-5472.SABCS10-P3-10-42""/> <meta name=""citation_reference"" content=""citation_journal_title=The Breast;citation_author=X. Ma;citation_author=L. Liu;citation_author=W. Nie;citation_author=Y. Li;citation_author=B. Zhang;citation_author=J. Zhang;citation_author=R. Zhou;citation_title=Prognostic role of caveolin in breast cancer: a meta-analysis;citation_pages=462-469;citation_volume=22;citation_year=2013;citation_doi=10.1016/j.breast.2013.03.005""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=AJ. Minn;citation_author=GP. Gupta;citation_author=PM. Siegel;citation_author=PD. Bos;citation_author=W. Shu;citation_author=DD. Giri;citation_author=A. Viale;citation_author=AB. Olshen;citation_author=WL. Gerald;citation_author=J. Massague;citation_title=Genes that mediate breast cancer metastasis to lung;citation_pages=518-524;citation_volume=436;citation_year=2005;citation_doi=10.1038/nature03799""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews. Molecular Cell Biology;citation_author=RG. Parton;citation_author=MA. del Pozo;citation_title=Caveolae as plasma membrane sensors, protectors and organizers;citation_pages=98-112;citation_volume=14;citation_year=2013;citation_doi=10.1038/nrm3512""/> <meta name=""citation_reference"" content=""citation_journal_title=BMC Medicine;citation_author=PP. Provenzano;citation_author=KW. Eliceiri;citation_author=JM. Campbell;citation_author=DR. Inman;citation_author=JG. White;citation_author=PJ. Keely;citation_title=Collagen reorganization at the tumor-stromal interface facilitates local invasion;citation_pages=38;citation_volume=4;citation_year=2006;citation_doi=10.1186/1741-7015-4-38""/> <meta name=""citation_reference"" content=""citation_journal_title=The Journal of Biological Chemistry;citation_author=B. Razani;citation_author=JA. Engelman;citation_author=XB. Wang;citation_author=W. Schubert;citation_author=XL. Zhang;citation_author=CB. Marks;citation_author=F. Macaluso;citation_author=RG. Russell;citation_author=M. Li;citation_author=RG. Pestell;citation_author=D. Di Vizio;citation_author=H. Hou Jr;citation_author=B. Kneitz;citation_author=G. Lagaud;citation_author=GJ. Christ;citation_author=W. Edelmann;citation_author=MP. Lisanti;citation_title=Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities;citation_pages=38121-38138;citation_volume=276;citation_year=2001;citation_doi=10.1074/jbc.M008340200""/> <meta name=""citation_reference"" content=""citation_journal_title=Virchows Archiv;citation_author=M. Ren;citation_author=F. Liu;citation_author=Y. Zhu;citation_author=Y. Li;citation_author=R. Lang;citation_author=Y. Fan;citation_author=F. Gu;citation_author=X. Zhang;citation_author=L. Fu;citation_title=Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome;citation_pages=291-298;citation_volume=465;citation_year=2014;citation_doi=10.1007/s00428-014-1614-6""/> <meta name=""citation_reference"" content=""citation_journal_title=American Journal of Clinical Pathology;citation_author=L. Righi;citation_author=MC. Cavallo;citation_author=G. Gatti;citation_author=V. Monica;citation_author=I. Rapa;citation_author=S. Busso;citation_author=C. Albera;citation_author=M. Volante;citation_author=GV. Scagliotti;citation_author=M. Papotti;citation_title=Tumor/stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis;citation_pages=816-827;citation_volume=141;citation_year=2014;citation_doi=10.1309/AJCP0F6WYBXGVDHX""/> <meta name=""citation_reference"" content=""citation_journal_title=International Journal of Radiation Biology;citation_author=M. Shatz;citation_author=M. Liscovitch;citation_title=Caveolin-1: a tumor-promoting role in human cancer;citation_pages=177-189;citation_volume=84;citation_year=2008;citation_doi=10.1080/09553000701745293""/> <meta name=""citation_reference"" content=""citation_journal_title=The Journal of Pathology;citation_author=SA. Simpkins;citation_author=AM. Hanby;citation_author=DL. Holliday;citation_author=V. Speirs;citation_title=Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts;citation_pages=490-498;citation_volume=227;citation_year=2012;citation_doi=10.1002/path.4034""/> <meta name=""citation_reference"" content=""citation_journal_title=Annual Review of Pathology;citation_author=F. Sotgia;citation_author=UE. Martinez-Outschoorn;citation_author=A. Howell;citation_author=RG. Pestell;citation_author=S. Pavlides;citation_author=MP. Lisanti;citation_title=Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms;citation_pages=423-467;citation_volume=7;citation_year=2012;citation_doi=10.1146/annurev-pathol-011811-120856""/> <meta name=""citation_reference"" content=""citation_journal_title=R Foundation for Statistical Computing;citation_author=R Development Core Team;citation_title=R: a language and environment for statistical computing;citation_year=2014""/> <meta name=""citation_reference"" content=""citation_journal_title=Experimental and Molecular Pathology;citation_author=G. Yang;citation_author=TL. Timme;citation_author=K. Naruishi;citation_author=T. Fujita;citation_author=MA. Fattah el;citation_author=G. Cao;citation_author=K. Rajagopalan;citation_author=LD. Troung;citation_author=TC. Thompson;citation_title=Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation;citation_pages=131-140;citation_volume=84;citation_year=2008;citation_doi=10.1016/j.yexmp.2007.08.004""/> <meta name=""citation_reference"" content=""citation_journal_title=PLOS ONE;citation_author=X. Zhao;citation_author=Y. He;citation_author=J. Gao;citation_author=L. Fan;citation_author=Z. Li;citation_author=G. Yang;citation_author=H. Chen;citation_title=Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer;citation_pages=e59102;citation_volume=8;citation_year=2013;citation_doi=10.1371/journal.pone.0059102""/>",7/16/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:41,e04796,,,4,,,Registered report,,,,,,,en,"© 2015, Fiering et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.",,,,elifesciences.org,,00000  Citation Key: fiering_registered_2015-1 00000  PMID: 26179155,,,,,Human; methodology; Mouse; metastasis; reproducibility project: cancer biology; biochemical remodeling; tumor microenvironment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FA9UHCTA,journalArticle,2015,"Li, Jia; Lam, Matthew; Reproducibility Project: Cancer Biology",Registered report: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44,Biology,eLife,,2050-084X,10/gf9h5w,http://elifesciences.org/lookup/doi/10.7554/eLife.06434,,7/31/2015,10/18/2020 17:37,10/18/2020 17:37,5/22/2017 18:08,,,,4,,,Registered report,,,,,,,en,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NJEPARWT,journalArticle,2015,"Evans, James; Essex, Anthony; Xin, Hong; Amitai, Nurith; Brinton, Lindsey; Griner, Erin",Registered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment,Biology,eLife,,2050-084X,10/gf9h5t,http://elifesciences.org/lookup/doi/10.7554/eLife.07301,,8/19/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:57,,,,4,,,Registered report,,,,,,,en,,,,,CrossRef,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4V2IT8GU,journalArticle,2015,"Khan, Israr; Kerwin, John; Owen, Kate; Griner, Erin",Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology,Biology,eLife,,2050-084X,10.7554/eLife.08245,http://elifesciences.org/lookup/doi/10.7554/eLife.08245,,9/3/2015,10/18/2020 17:37,10/18/2020 17:37,5/18/2016 18:56,,,,4,,,Registered report,,,,,,,en,,,,,CrossRef,,Citation Key: khan_registered_2015 00000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNM4PZGB,journalArticle,2015,"Shan, Xiaochuan; Danet-Desnoyers, Gwenn; Fung, Juan José; Kosaka, Alan H.; Tan, Fraser; Perfito, Nicole; Lomax, Joelle; Iorns, Elizabeth",Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer,Biology,PeerJ,,2167-8359,10.7717/peerj.1232,https://peerj.com/articles/1232,,9/15/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:23,e1232,,,3,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KSVP2Z5W,journalArticle,2016,"Lesnik, Jake; Antes, Travis; Kim, Jeewon; Griner, Erin; Pedro, Luisa; Reproducibility Project: Cancer Biology",Registered report: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET,Biology,eLife,,2050-084X,10.7554/eLife.07383,https://elifesciences.org/articles/07383,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (<xref ref-type=""bibr"" rid=""bib1"">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from “Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET” by Peinado and colleagues, published in Nature Medicine in 2012 (<xref ref-type=""bibr"" rid=""bib7"">Peinado et al., 2012</xref>). The key experiments being replicated are from Figures 4E, as well as Supplementary Figures 1C and 5A. In these experiments, Peinado and colleagues show tumor exosomes enhance metastasis to bones and lungs, which is diminished by reducing Met expression in exosomes (<xref ref-type=""bibr"" rid=""bib1"">Peinado et al., 2012</xref>). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published in eLife.",1/29/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:22,e07383,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DG3WPUCK,journalArticle,2016,"Bhargava, Ajay; Pelech, Steven; Woodard, Ben; Kerwin, John; Maherali, Nimet; Reproducibility Project: Cancer Biology",Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth,Biology,eLife,,2050-084X,10.7554/eLife.09976,https://elifesciences.org/articles/09976,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (<xref ref-type=""bibr"" rid=""bib2"">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from 'RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth' by Hatzivassiliou and colleagues, published in Nature in 2010 (<xref ref-type=""bibr"" rid=""bib7"">Hatzivassiliou et al., 2010</xref>). Hatzivassiliou and colleagues examined the paradoxical response of RAF-WT tumors to treatment with RAF inhibitors. The key experiments being replicated include Figure 1A, in which the original authors demonstrated that treatment of a subset of BRAFWT tumor cell lines with RAF small molecule inhibitors resulted in an increase in cell viability, Figure 2B, which reported that RAF inhibitor activation of the MAPK pathway was dependent on CRAF but not BRAF, and Figure 4A, where the dimerization of BRAF and CRAF was modulated by the RAF inhibitor PLX4720, but not GDC-0879. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",2/16/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:10,e09976,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
B8QGW9QE,journalArticle,2016,"Bhargava, Ajay; Anant, Madan; Mack, Hildegard; Reproducibility Project: Cancer Biology",Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF,Biology,eLife,,2050-084X,10.7554/eLife.11999,https://elifesciences.org/articles/11999,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (<xref ref-type=""bibr"" rid=""bib4"">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from ""Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF"" by Heidorn and colleagues, published in Cell in 2010 (<xref ref-type=""bibr"" rid=""bib9"">Heidorn et al., 2010</xref>). The experiments to be replicated are those reported in Figures 1A, 1B, 3A, 3B, and 4D. Heidorn and colleagues report that paradoxical activation of the RAF-RAS-MEK-ERK pathway by BRAF inhibitors when applied to BRAFWT cells is a result of BRAF/CRAF heterodimer formation upon inactivation of BRAF kinase activity, and occurs only in the context of active RAS. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.",2/17/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:16,e11999,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPFPK2BZ,journalArticle,2016,"Haven, Babette; Heilig, Elysia; Donham, Cristine; Settles, Michael; Vasilevsky, Nicole; Owen, Katherine; Reproducibility Project: Cancer Biology",Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations,Biology,eLife,,2050-084X,10.7554/eLife.09462,https://elifesciences.org/articles/09462,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a substantial number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (Errington et al., 2014). This Registered Report describes the proposed replication plan of experiments from “A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations” by Sharma and colleagues, published in Cell in 2010 (Sharma et al., 2010). Sharma and colleagues demonstrated that prolonged exposure of cancer cells to TKIs give rise to small populations of “drug tolerant persisters” (DTPs) (Figure 1B-C) that were reversed during subsequent maintenance under drug-free conditions (Figures 1E, 2B and 2E). DTPs exhibited reduced histone acetylation and sensitivity to HDAC inhibitors (HDIs) (Figure 4A-B). Drug sensitivity was restored with co-treatment of either HDIs or an IGF-1R inhibitor, in combination with TKIs (Figure 5A-B). Inhibition of IGF-1R activation also led to decreased KDM5A expression and restoration of H3K4 methylation, suggesting a direct link between the IGF-1R signaling pathway and KDM5A function (Figure 7A, 7C, and 7I). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published in eLife.",2/23/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:19,e09462,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
UE8Q8WRV,journalArticle,2016,"Fiehn, Oliver; Showalter, Megan Reed; Schaner-Tooley, Christine E; Reproducibility Project: Cancer Biology",Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate,Biology,eLife,,2050-084X,10.7554/eLife.12626,https://elifesciences.org/articles/12626,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (<xref ref-type=""bibr"" rid=""bib3"">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from “The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate” by Ward and colleagues, published in Cancer Cell in 2010 (<xref ref-type=""bibr"" rid=""bib16"">Ward et al., 2010</xref>). The experiments that will be replicated are those reported in Figures 2, 3 and 5. Ward and colleagues demonstrate the mutations in isocitrate dehydrogenase 2 (IDH2), commonly found in acute myeloid leukemia (AML), abrogate the enzyme’s wild-type activity and confer to the mutant neomorphic activity that produces the oncometabolite 2-hydroxyglutarate (2-HG) (Figures 2 and 3). They then show that elevated levels of 2-HG are correlated with mutations in IDH1 and IDH2 in AML patient samples (Figure 5). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published by eLife.",2/26/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:17,e12626,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AK4AT7P2,journalArticle,2015,"Chronscinski, Denise; Cherukeri, Srujana; Tan, Fraser; Perfito, Nicole; Lomax, Joelle; Iorns, Elizabeth",Registered report: the androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man,Biology,PeerJ,,2167-8359,10.7717/peerj.1231,https://peerj.com/articles/1231,,9/15/2015,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:11,e1231,,,3,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
9JPC6IR4,journalArticle,2016,"Nitta, Hiroshi; Tomita, Haruto; Zhang, Yi; Zhou, Xinxin; Yamada, Yuki","Disgust and the rubber hand illusion: A registered replication report of Jalal, Krishnakumar, and Ramachandran (2015)",Psychology,PsyArXiv,,,10.17605/OSF.IO/22MYU,,"Heightened experience of disgust is a feature of obsessive-compulsive disorder (OCD), particularly in contamination-related OCD (C-OCD). Previous studies of the rubber hand illusion (RHI) reported that the sense of body ownership is related to the interaction between vision, touch, and proprioception. A recent study demonstrated a link between the RHI and disgust, reporting an interaction between these three perceptual modalities and disgust (Jalal, Krishnakumar, Ramachandran, 2015). However, there have been no direct replications of this initial study. We proposed a direct replication of Jalal et al.’s (2015) study. Based on a power analysis, we examined a minimum of 119 participants to determine whether placing contamination-related stimuli on a rubber hand causes OCD-like disgust among healthy participants while experiencing the RHI. In addition, we tested the cross-cultural validity of the previous findings, testing whether Japanese participants experience more intense disgust when a rubber hand and a participant’s hidden hand were stroked synchronously, compared with asynchronous stroking. This replication provides insight into potential applications of this study protocol in the treatment of OCD.",2016,10/18/2020 17:37,10/18/2020 17:37,,-,,,,,,Disgust and the rubber hand illusion,,,,,,,,,,,,DataCite,,ZSCC: 0000000[s0],,,,⛔ No DOI found,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DXMZEG9M,journalArticle,2016,"Repass, John; Maherali, Nimet; Owen, Kate; Biology, Reproducibility Project: Cancer",Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma,Biology,eLife,,2050-084X,10/gf9h5m,https://elifesciences.org/content/5/e10012v1,"<meta name=""DC.Rights"" content=""© 2016, Repass et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.""/> <meta name=""DC.Contributor"" content=""John Repass""/> <meta name=""DC.Contributor"" content=""Nimet Maherali""/> <meta name=""DC.Contributor"" content=""Kate Owen""/> <meta name=""DC.Contributor"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""DC.Contributor"" content=""Cynthia L Sears""/> <meta name=""DC.Contributor"" content=""Elizabeth Iorns""/> <meta name=""DC.Contributor"" content=""William Gunn""/> <meta name=""DC.Contributor"" content=""Fraser Tan""/> <meta name=""DC.Contributor"" content=""Joelle Lomax""/> <meta name=""DC.Contributor"" content=""Nicole Perfito""/> <meta name=""DC.Contributor"" content=""Timothy Errington""/> <meta name=""citation_funding_source"" content=""citation_funder=Laura and John Arnold Foundation;citation_grant_number=;citation_grant_recipient= ""/> <meta name=""citation_author"" content=""John Repass""/> <meta name=""citation_author_institution"" content=""ARQ Genetics""/> <meta name=""citation_author"" content=""Nimet Maherali""/> <meta name=""citation_author_institution"" content=""Harvard Stem Cell Institute""/> <meta name=""citation_author"" content=""Kate Owen""/> <meta name=""citation_author_institution"" content=""University of Virginia""/> <meta name=""citation_author"" content=""Reproducibility Project: Cancer Biology""/> <meta name=""citation_author_email"" content=""nicole@scienceexchange.com""/> <meta name=""citation_reference"" content=""citation_journal_title=Frontiers in Immunology;citation_author=M-C. Arrieta;citation_author=LT. Stiemsma;citation_author=N. Amenyogbe;citation_author=EM. Brown;citation_author=B. Finlay;citation_title=The intestinal microbiome in early life: health and disease;citation_pages=427;citation_volume=5;citation_year=2014;citation_doi=10.3389/fimmu.2014.00427""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature;citation_author=M. Bajzer;citation_author=RJ. Seeley;citation_title=Physiology: obesity and gut flora;citation_pages=1009-1010;citation_volume=444;citation_year=2006;citation_doi=10.1038/4441009a""/> <meta name=""citation_reference"" content=""citation_journal_title=Nutrients;citation_author=K. Brown;citation_author=D. DeCoffe;citation_author=E. Molcan;citation_author=DL. Gibson;citation_title=Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease;citation_pages=1095-1119;citation_volume=4;citation_year=2012;citation_doi=10.3390/nu4081095""/> <meta name=""citation_reference"" content=""citation_journal_title=Science;citation_author=F. Bäckhed;citation_author=RE. Ley;citation_author=JL. Sonnenburg;citation_author=DA. Peterson;citation_author=JI. Gordon;citation_title=Host-bacterial mutualism in the human intestine;citation_pages=1915-1920;citation_volume=307;citation_year=2005;citation_doi=10.1126/science.1104816""/> <meta name=""citation_reference"" content=""citation_journal_title=Genome Research;citation_author=M. Castellarin;citation_author=RL. Warren;citation_author=JD. Freeman;citation_author=L. Dreolini;citation_author=M. Krzywinski;citation_author=J. Strauss;citation_author=R. Barnes;citation_author=P. Watson;citation_author=E. Allen-Vercoe;citation_author=RA. Moore;citation_author=RA. Holt;citation_title=Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma;citation_pages=299-306;citation_volume=22;citation_year=2012;citation_doi=10.1101/gr.126516.111""/> <meta name=""citation_reference"" content=""citation_journal_title=American Journal of Clinical Nutrition;citation_author=H-M. Chen;citation_author=Y-N. Yu;citation_author=J-L. Wang;citation_author=Y-W. Lin;citation_author=X. Kong;citation_author=C-Q. Yang;citation_author=L. Yang;citation_author=Z-J. Liu;citation_author=Y-Z. Yuan;citation_author=F. Liu;citation_author=J-X. Wu;citation_author=L. Zhong;citation_author=D-C. Fang;citation_author=W. Zou;citation_author=J-Y. Fang;citation_title=Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma;citation_pages=1044-1052;citation_volume=97;citation_year=2013;citation_doi=10.3945/ajcn.112.046607""/> <meta name=""citation_reference"" content=""citation_journal_title=Nature Reviews Gastroenterology &amp; Hepatology;citation_author=SM. Collins;citation_title=A role for the gut microbiota in IBS;citation_pages=497-505;citation_volume=11;citation_year=2014;citation_doi=10.1038/nrgastro.2014.40""/> <meta name=""citation_reference"" content=""citation_journal_title=The Cancer Journal;citation_author=S. Dulal;citation_author=TO. Keku;citation_title=Gut microbiome and colorectal adenomas;citation_pages=225-231;citation_volume=20;citation_year=2014;citation_doi=10.1097/PPO.0000000000000050""/> <meta name=""citation_reference"" content=""citation_journal_title=eLife;citation_author=TM. Errington;citation_author=E. Iorns;citation_author=W. Gunn;citation_author=FE. Tan;citation_author=J. Lomax;citation_author=BA. Nosek;citation_title=An open investigation of the reproducibility of cancer biology research;citation_volume=3;citation_year=2014;citation_doi=10.7554/eLife.04333""/> <meta name=""citation_reference"" content=""citation_journal_title=Behavior Research Methods;citation_author=F. Faul;citation_author=E. Erdfelder;citation_author=A-G. Lang;citation_author=A. Buchner;citation_title=G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences;citation_pages=175-191;citation_volume=39;citation_year=2007;citation_doi=10.3758/BF03193146""/> <meta name=""citation_reference"" content=""citation_journal_title=Annual Review of Pathology: Mechanisms of Disease;citation_author=ER. Fearon;citation_title=Molecular genetics of colorectal cancer;citation_pages=479-507;citation_volume=6;citation_year=2011;citation_doi=10.1146/annurev-pathol-011110-130235""/> <meta name=""citation_reference"" content=""citation_journal_title=European Journal of Clinical Microbiology &amp; Infectious Diseases;citation_author=L. Flanagan;citation_author=J. Schmid;citation_author=M. Ebert;citation_author=P. Soucek;citation_author=T. Kunicka;citation_author=V. Liska;citation_author=J. Bruha;citation_author=P. Neary;citation_author=N. Dezeeuw;citation_author=M. Tommasino;citation_author=M. Jenab;citation_author=JH. Prehn;citation_author=DJ. Hughes;citation_title=Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome;citation_pages=1381-1390;citation_volume=33;citation_year=2014;citation_doi=10.1007/s10096-014-2081-3""/> <meta name=""citation_reference"" content=""citation_journal_title=Immunity;citation_author=C. Gur;citation_author=Y. Ibrahim;citation_author=B. Isaacson;citation_author=R. Yamin;citation_author=J. Abed;citation_author=M. Gamliel;citation_author=J. Enk;citation_author=Y. Bar-On;citation_author=N. Stanietsky-Kaynan;citation_author=S. Coppenhagen-Glazer;citation_author=N. Shussman;citation_author=G. Almogy;citation_author=A. Cuapio;citation_author=E. Hofer;citation_author=D. Mevorach;citation_author=A. Tabib;citation_author=R. Ortenberg;citation_author=G. Markel;citation_author=K. Miklić;citation_author=S. Jonjic;citation_author=CA. Brennan;citation_author=WS. Garrett;citation_author=G. Bachrach;citation_author=O. Mandelboim;citation_title=Binding of the Fap2 protein of fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack;citation_pages=344-355;citation_volume=42;citation_year=2015;citation_doi=10.1016/j.immuni.2015.01.010""/> <meta name=""citation_reference"" content=""citation_journal_title=World Journal of Gastroenterology;citation_author=GL. Hold;citation_author=M. Smith;citation_author=C. Grange;citation_author=ER. Watt;citation_author=EM. El-Omar;citation_author=I. Mukhopadhya;citation_title=Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?;citation_pages=1192-1210;citation_volume=20;citation_year=2014;citation_doi=10.3748/wjg.v20.i5.1192""/> <meta name=""citation_reference"" content=""citation_journal_title=Trends in Microbiology;citation_author=ML. Jones;citation_author=C. Tomaro-Duchesneau;citation_author=S. Prakash;citation_title=The gut microbiome, probiotics, bile acids axis, and human health;citation_pages=306-308;citation_volume=22;citation_year=2014;citation_doi=10.1016/j.tim.2014.04.010""/> <meta name=""citation_reference"" content=""citation_journal_title=American Journal of Physiology - Gastrointestinal and Liver Physiology;citation_author=TO. Keku;citation_author=S. Dulal;citation_author=A. Deveaux;citation_author=B. Jovov;citation_author=X. Han;citation_title=The gastrointestinal microbiota and colorectal cancer;citation_pages=G351-G363;citation_volume=308;citation_year=2015;citation_doi=10.1152/ajpgi.00360.2012""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell Host &amp; Microbe;citation_author=AD. Kostic;citation_author=E. Chun;citation_author=L. Robertson;citation_author=JN. Glickman;citation_author=CA. Gallini;citation_author=M. Michaud;citation_author=TE. Clancy;citation_author=DC. Chung;citation_author=P. Lochhead;citation_author=GL. Hold;citation_author=EM. El-Omar;citation_author=D. Brenner;citation_author=CS. Fuchs;citation_author=M. Meyerson;citation_author=WS. Garrett;citation_title=Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment;citation_pages=207-215;citation_volume=14;citation_year=2013;citation_doi=10.1016/j.chom.2013.07.007""/> <meta name=""citation_reference"" content=""citation_journal_title=Genome Research;citation_author=AD. Kostic;citation_author=D. Gevers;citation_author=CS. Pedamallu;citation_author=M. Michaud;citation_author=F. Duke;citation_author=AM. Earl;citation_author=AI. Ojesina;citation_author=J. Jung;citation_author=AJ. Bass;citation_author=J. Tabernero;citation_author=J. Baselga;citation_author=C. Liu;citation_author=RA. Shivdasani;citation_author=S. Ogino;citation_author=BW. Birren;citation_author=C. Huttenhower;citation_author=WS. Garrett;citation_author=M. Meyerson;citation_title=Genomic analysis identifies association of fusobacterium with colorectal carcinoma;citation_pages=292-298;citation_volume=22;citation_year=2012;citation_doi=10.1101/gr.126573.111""/> <meta name=""citation_reference"" content=""citation_journal_title=Nihon Shokakibyo Gakkai Zasshi;citation_author=Y. Kubota;citation_title=[Fecal intestinal flora in patients with colon adenoma and colon cancer];citation_pages=771-779;citation_volume=87;citation_year=1990""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell;citation_author=RE. Ley;citation_author=DA. Peterson;citation_author=JI. Gordon;citation_title=Ecological and evolutionary forces shaping microbial diversity in the human intestine;citation_pages=837-848;citation_volume=124;citation_year=2006;citation_doi=10.1016/j.cell.2006.02.017""/> <meta name=""citation_reference"" content=""citation_journal_title=PLoS ONE;citation_author=AN. McCoy;citation_author=F. Araújo-Pérez;citation_author=A. Azcárate-Peril;citation_author=JJ. Yeh;citation_author=RS. Sandler;citation_author=TO. Keku;citation_author=A. Goel;citation_title=Fusobacterium is associated with colorectal adenomas;citation_volume=8;citation_year=2013;citation_doi=10.1371/journal.pone.0053653""/> <meta name=""citation_reference"" content=""citation_journal_title=Journal of Gastroenterology;citation_author=L. Mira-Pascual;citation_author=R. Cabrera-Rubio;citation_author=S. Ocon;citation_author=P. Costales;citation_author=A. Parra;citation_author=A. Suarez;citation_author=F. Moris;citation_author=L. Rodrigo;citation_author=A. Mira;citation_author=MC. Collado;citation_title=Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers;citation_pages=167-179;citation_volume=50;citation_year=2015;citation_doi=10.1007/s00535-014-0963-x""/> <meta name=""citation_reference"" content=""citation_journal_title=Oncoscience;citation_author=R. Mundade;citation_author=TF. Imperiale;citation_author=L. Prabhu;citation_author=PJ. Loehrer;citation_author=T. Lu;citation_title=Genetic pathways, prevention, and treatment of sporadic colorectal cancer;citation_pages=400-406;citation_volume=1;citation_year=2014;citation_doi=10.18632/oncoscience.59""/> <meta name=""citation_reference"" content=""citation_journal_title=Journal of Proteome Research;citation_author=JL. Nugent;citation_author=AN. McCoy;citation_author=CJ. Addamo;citation_author=W. Jia;citation_author=RS. Sandler;citation_author=TO. Keku;citation_title=Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas;citation_pages=1921-1929;citation_volume=13;citation_year=2014;citation_doi=10.1021/pr4009783""/> <meta name=""citation_reference"" content=""citation_journal_title=Microbial Ecology in Health &amp; Disease;citation_author=JM. Rodríguez;citation_author=K. Murphy;citation_author=C. Stanton;citation_author=RP. Ross;citation_author=OI. Kober;citation_author=N. Juge;citation_author=E. Avershina;citation_author=K. Rudi;citation_author=A. Narbad;citation_author=MC. Jenmalm;citation_author=JR. Marchesi;citation_author=MC. Collado;citation_title=The composition of the gut microbiota throughout life, with an emphasis on early life;citation_pages=26050;citation_volume=26;citation_year=2015;citation_doi=10.3402/mehd.v26.26050""/> <meta name=""citation_reference"" content=""citation_journal_title=Cell Host &amp; Microbe;citation_author=MR. Rubinstein;citation_author=X. Wang;citation_author=W. Liu;citation_author=Y. Hao;citation_author=G. Cai;citation_author=YW. Han;citation_title=Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating e-cadherin/-catenin signaling via its FadA adhesinn;citation_pages=195-206;citation_volume=14;citation_year=2013;citation_doi=10.1016/j.chom.2013.07.012""/> <meta name=""citation_reference"" content=""citation_journal_title=Cancer Research;citation_author=T. Tahara;citation_author=E. Yamamoto;citation_author=H. Suzuki;citation_author=R. Maruyama;citation_author=W. Chung;citation_author=J. Garriga;citation_author=J. Jelinek;citation_author=H.-o.. Yamano;citation_author=T. Sugai;citation_author=B. An;citation_author=I. Shureiqi;citation_author=M. Toyota;citation_author=Y. Kondo;citation_author=MRH. Estecio;citation_author=J-PJ. Issa;citation_title=Fusobacterium in colonic flora and molecular features of colorectal carcinoma;citation_pages=1311-1318;citation_volume=74;citation_year=2014;citation_doi=10.1158/0008-5472.CAN-13-1865""/> <meta name=""citation_reference"" content=""citation_author=RC. Team;citation_title=R: a language and environment for statistical computing;citation_year=2014""/> <meta name=""citation_reference"" content=""citation_journal_title=New England Journal of Medicine;citation_author=B. Vogelstein;citation_author=ER. Fearon;citation_author=SR. Hamilton;citation_author=SE. Kern;citation_author=AC. Preisinger;citation_author=M. Leppert;citation_author=Y. Nakamura;citation_author=R. White;citation_author=AM. Smits;citation_author=JL. Bos;citation_title=Genetic alterations during colorectal-tumor development;citation_pages=525-532;citation_volume=319;citation_year=1988;citation_doi=10.1056/NEJM198809013190901""/> <meta name=""citation_reference"" content=""citation_journal_title=Microbiome;citation_author=RL. Warren;citation_author=DJ. Freeman;citation_author=S. Pleasance;citation_author=P. Watson;citation_author=RA. Moore;citation_author=K. Cochrane;citation_author=E. Allen-Vercoe;citation_author=RA. Holt;citation_title=Co-occurrence of anaerobic bacteria in colorectal carcinomas;citation_pages=16;citation_volume=1;citation_year=2013;citation_doi=10.1186/2049-2618-1-16""/>",2/11/2016,10/18/2020 17:37,10/18/2020 17:37,8/31/2016 16:07,e10012,,,5,,,Registered report,,,,,,,en,"© 2016, Repass et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.",,,,elifesciences.org,,https://osf.io/v4se2,,,,,Human; reproducibility project: cancer biology; <italic>fusobacterium nucleatum</italic>; colorectal carcinoma; methodolgy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
XR23S69K,journalArticle,2016,"Sharma, Vidhu; Young, Lisa; Allison, Anne B; Owen, Kate; Reproducibility Project: Cancer Biology",Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers,Biology,eLife,,2050-084X,10.7554/eLife.11566,https://elifesciences.org/articles/11566,"The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (<xref ref-type=""bibr"" rid=""bib12"">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from ""Diverse somatic mutation patterns and pathway alterations in human cancers"" by Kan and colleagues published in Nature in 2010 (<xref ref-type=""bibr"" rid=""bib24"">Kan et al., 2010</xref>). The experiments to be replicated are those reported in Figures 3D-F and 4C-F. Kan and colleagues utilized mismatch repair detection (MRD) technology to identify somatic mutations in primary human tumor samples and identified a previously uncharacterized arginine 243 to histidine (R243H) mutation in the G-protein α subunit GNAO1 in breast carcinoma tissue. In Figures 3D-F, Kan and colleagues demonstrated that stable expression of mutant GNAO1R243D conferred a significant growth advantage in human mammary epithelial cells, confirming the oncogenic potential of this mutation. Similarly, expression of variants with somatic mutations in MAP2K4, a JNK pathway kinase (shown in Figures 4C-E) resulted in a significant increase in anchorage-independent growth. Interestingly, these mutants exhibited reduced kinase activity compared to wild type MAP2K4, indicating these mutations impose a dominant-negative influence to promote growth (Figure 4F). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published in eLife.",2/19/2016,10/18/2020 17:37,10/18/2020 17:37,12/18/2019 17:24,e11566,,,5,,,Registered report,,,,,,,en,,,,,DOI.org (Crossref),,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ZM9RMT8V,journalArticle,2018,"Mühlenen, Adrian von; Bellaera, Lauren; Singh, Amrendra; Srinivasan, Narayanan",The effect of sadness on global-local processing,Psychology,"Attention, Perception, & Psychophysics",,"1943-3921, 1943-393X",10/gdv69k,https://link.springer.com/article/10.3758/s13414-018-1534-7,"Gable and Harmon-Jones (Psychological Science, 21(2), 211-215, 2010) reported that sadness broadens attention in a global-local letter task. This finding provided the key test for their motivational intensity account, which states that the level of spatial processing is not determined by emotional valence, but by motivational intensity. However, their finding is at odds with several other studies, showing no effect, or even a narrowing effect of sadness on attention. This paper reports two attempts to replicate the broadening effect of sadness on attention. Both experiments used a global-local letter task, but differed in terms of emotion induction: Experiment 1 used the same pictures as Gable and Harmon-Jones, taken from the IAPS dataset; Experiment 2 used a sad video underlaid with sad music. Results showed a sadness-specific global advantage in the error rates, but not in the reaction times. The same null results were also found in a South-Asian sample in both experiments, showing that effects on global/local processing were not influenced by a culturally related processing bias.",5/4/2018,10/18/2020 17:37,10/18/2020 17:37,5/8/2018 14:11,11-Jan,,,,,Atten Percept Psychophys,,,,,,,,en,,,,,link.springer.com,,0,<p>Determined this was a Registered Report from this editorial summarizing the RRR special issue: https://link.springer.com/article/10.3758/s13414-013-0502-5</p>,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BJFXII9C,journalArticle,2019,"Richardson, Amy; Richard, Lauralie; Gunter, Kathryn; Derrett, Sarah",Interventions to integrate care for people with serious mental illness and substance use disorders: a systematic scoping review protocol,Psychology,BMJ Open,,"2044-6055, 2044-6055",10.1136/bmjopen-2019-031122,https://bmjopen.bmj.com/content/9/10/e031122,"Introduction People with serious mental illness (SMI) and/or substance use disorders (SUDs) have an elevated risk of premature mortality compared with the general population. This has been attributed to higher rates of chronic illness among these individuals, but also to inequities in healthcare access and treatment. Integrated care has the potential to improve the health of people with SMI/SUDs. The aims of this scoping review are to: (1) identify empirical investigations of interventions designed to integrate care for people with SMI/SUDs; (2) describe the underlying theories, models and frameworks of integrated care that informed their development; and (3) determine the degree to which interventions address dimensions of a comprehensive and validated framework of integrated care. Methods and analysis Guidelines for best practice and reporting of scoping reviews will be followed using the framework of Arksey and O’Malley and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses scoping review checklist. An iterative and systematic search of peer-reviewed publications reporting empirical research findings will be conducted. This literature will be identified by searching five databases: Medline (Ovid), PsycINFO, CINAHL, Embase (Ovid) and Scopus. The search will be restricted to articles published between January 2000 and April 2019. Two reviewers will independently screen publications in two successive stages of title and abstract screening, followed by full-text screening of eligible publications. A tabular summary and narrative synthesis will be completed using data extracted from each included study. A framework synthesis will also be conducted, with descriptions of interventions mapped against a theoretical framework of integrated care. Ethics and dissemination This review will identify the extent and nature of empirical investigations evaluating interventions to integrate care for people with SMI/SUDs. Ethical approval was not required. A team of relevant stakeholders, including people with lived experience of mental health conditions, has been established. This team will be engaged throughout the review and will ensure that the findings are widely disseminated. Dissemination will include publication of the review in a peer-reviewed journal. The review protocol has been registered through Open Science Framework and can be accessed at https://osf.io/njkph/",10/1/2019,10/18/2020 17:37,10/18/2020 17:37,3/5/2020 20:34,e031122,,10,9,,,Interventions to integrate care for people with serious mental illness and substance use disorders,,,,,,,en,"© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.",,,,bmjopen.bmj.com,,https://osf.io/njkph/,,,http://www.ncbi.nlm.nih.gov/pubmed/31666268,,review; interventions; substance-related disorders; delivery of health care; integrated; severe mental disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
